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AbstrACt
Introduction Chronic kidney disease (CKD) requires 
patients and caregivers to invest in self-care and self-
management of their disease. We aimed to describe the 
work for adult patients that follows from these investments 
and develop an understanding of burden of treatment 
(BoT).
Methods Systematic review of qualitative primary 
studies that builds on EXPERTS1 Protocol, PROSPERO 
registration number: CRD42014014547. We included 
research published in English, Spanish and Portuguese, 
from 2000 to present, describing experience of illness 
and healthcare of people with CKD and caregivers. 
Searches were conducted in MEDLINE, Embase, CINAHL 
Plus, PsycINFO, Scopus, Scientific Electronic Library 
Online and Red de Revistas Científicas de América 
Latina y el Caribe, España y Portugal. Content was 
analysed with theoretical framework using middle-range 
theories.
results Searches resulted in 260 studies from 
30 countries (5115 patients and 1071 carers). 
Socioeconomic status was central to the experience 
of CKD, especially in its advanced stages when 
renal replacement treatment is necessary. Unfunded 
healthcare was fragmented and of indeterminate 
duration, with patients often depending on emergency 
care. Treatment could lead to unemployment, and in 
turn, to uninsurance or underinsurance. Patients feared 
catastrophic events because of diminished financial 
capacity and made strenuous efforts to prevent them. 
Transportation to and from haemodialysis centre, with 
variable availability and cost, was a common problem, 
aggravated for patients in non-urban areas, or with 
young children, and low resources. Additional work for 
those uninsured or underinsured included fund-raising. 
Transplanted patients needed to manage finances and 
responsibilities in an uncertain context. Information on 
the disease, treatment options and immunosuppressants 
side effects was a widespread problem.
Conclusions Being a person with end-stage kidney 
disease always implied high burden, time-consuming, 
invasive and exhausting tasks, impacting on all aspects 
of patients' and caregivers’ lives. Further research on 
BoT could inform healthcare professionals and policy 
makers about factors that shape patients’ trajectories and 
contribute towards a better illness experience for those 
living with CKD.
PrOsPErO registration number CRD42014014547.
IntrOduCtIOn
Chronic kidney disease (CKD) contrib-
utes significantly to global morbidity and 
mortality.1–4 Even in its early stages, the risk of 
death, cardiovascular events, cerebrovascular 
disorders, hospitalisation, reduced health-re-
lated quality of life, anxiety, depression and 
suicidal ideation is increased.1–6 
Worldwide, about 500 million people are 
affected by CKD; about 80% of these live in 
low-income and middle-income countries 
(LMIC); an estimated 3 million people with 
end-stage kidney disease (ESKD) receive 
renal replacement therapy (RRT) with either 
dialysis or transplantation.1 7 8 The number of 
people receiving RRT is increasing and will 
more than double by 2030, but a significant 
number of people without access to this type 
of live-saving treatment will remain.9 In 2010, 
at least 2.28 million people might have died 
because of lack of access to RRT, mostly in 
LMIC in Asia, Africa and Latin America.9
Much is now known about the pathophys-
iological and treatment trajectories of CKD, 
and about the associated burden of symp-
toms experienced by patients. More recently, 
there has been increasing interest in the way 
that complex long-term conditions require 
patients and their carers to invest in self-care 
and self-management of their disease.10–15 
The work for patients and carers that follows 
strengths and limitations of this study
 ► We analysed data with a coding framework sup-
ported by middle-range theories to understand the 
work involved in being a person with chronic kidney 
disease.
 ► Comprehensive inclusion of publications in English, 
Spanish and Portuguese, which may enhance the 
transferability of our findings.
 ► The variety of methodologies, quality of reporting 
and heterogeneity of perspectives make synthesis 
difficult.
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from these investments, including medication manage-
ment, medical visits, laboratory tests, lifestyle changes and 
monitoring in addition to the activities done as part of life, 
is here termed burden of treatment (BoT), which adds to 
the burden of symptoms (BoS).10 13 16 Research on BoT 
has focused on long-term conditions such as diabetes, 
chronic obstructive pulmonary disease and chronic heart 
failure, with the development of analytic framework and 
patient-created taxonomies.10 16–27 Patients and carers are 
expected to actively participate in managing both index 
conditions and comorbidities and, depending on their 
resources or lack thereof, they often need to negotiate or 
renegotiate the responsibilities that healthcare providers 
and healthcare systems assign to them.13 28 29 Patients' 
and carers’ experience in managing the disease and its 
treatment, including their choices and expectations, is 
affected by structural, relational and resilience factors; the 
interactions among these factors remain understudied.30 
The aim of this study is to develop specific understanding 
of treatment burden experienced by people with CKD 
and ESKD extending it to experiences of uninsured and 
underinsured patients in LMIC.
MEthOds
This is a systematic review of primary qualitative studies, 
which builds on the published EXPERTS1 Protocol and its 
meta-review of qualitative reviews.30 31 PROSPERO regis-
tration number is CRD42014014547. This review follows 
the Enhancing Transparency in Reporting the Synthesis 
of Qualitative Research framework.32 We interrogated a 
subset of qualitative primary research papers concerned 
with CKD identified by EXPERTS1 qualitative meta-re-
view to understand the dynamics of patient experience of 
complexity and treatment burden in long-term life-lim-
iting conditions. EXPERTS1 search was updated and 
expanded to Spanish and Portuguese language literature.
Eligibility, inclusion and exclusion criteria
Eligibility criteria for study inclusion were developed 
using the participants, interventions, comparators and 
outcomes framework (table 1). Inclusion criteria were 
primary qualitative and mixed-method studies of adult 
patients diagnosed with CKD in any stage and their 
formal or informal carers; in any type of treatment or 
healthcare provision; not limited to comparative studies; 
with qualitative data on the patients' and carers’ experi-
ences on any aspect of CKD, in any stage, and its treat-
ments; in English, Spanish and Portuguese. Following the 
EXPERTS1 protocol, studies were excluded if they were 
of other EXPERTS1 index conditions; if they reported 
results of treatments, interventions, tests or surveys; 
were guidelines, discussions of the literature or edito-
rials, notes, news, letters and case reports; if the expe-
riences described by patients and carers could not be 
clearly discriminated.31 Studies describing experiences 
of children with CKD were excluded because their BoT 
may be significantly different from that of adult patients. 
The year of publication 2000 onwards was established to 
include current treatments.
study selection
A first search for the EXPERTS1 meta-review was 
conducted in MEDLINE, Embase, CINAHL Plus, 
PsycINFO and Scopus. For this review, searches were 
updated using the same databases and expanded to 
include studies published in Spanish and Portuguese 
with additional searches in the Iberoamerican data-
bases Scientific Electronic Library Online and Red de 
Revistas Científicas de América Latina y el Caribe, España 
y Portugal. Searches were completed by April 2017 and 
identified papers published between 1 January 2000 
and March 2017. Search strategy is included in supple-
mentary appendix 1. For a first set of studies, titles and 
abstracts were independently screened by AC, MM and 
CRM, disagreements resolved by JH. Full-text papers 
(n=1238) were obtained and screened by JH, KAL and 
MM; disagreements resolved by KH or AC. Of 606 arti-
cles, 191 were related to CKD. For a second set, updated 
results in English and studies in Spanish and Portuguese 
were screened by JR, JPA, disagreements resolved by FC. 
Two authors (JR, JPA) assessed papers against the Crit-
ical Appraisal Skills Programme qualitative research 
checklist.33 As there is no accepted criteria for the exclu-
sion of qualitative studies-based appraisal score, we did 
not exclude studies based on quality. See figure 1 for 
screening and selection process.
data extraction and analysis
Data outlining study characteristics are shown in table 2. 
Manuscripts were entered into Atlas.Ti V.7.5.12 (Scien-
tific Software Development GmbH). The results sections 
and participant quotations of the primary studies were 
analysed line-by-line using directed content analysis, 
sometimes called framework analysis.34 The coding frame 
drew on concepts from the Burden of Treatment Theory 
and the Cognitive Authority Theory.18–21 29 35 36 Coding 
was conducted by JR and CRM, with a third party involved 
for disagreements (JPA), and reviewed and discussed by 
Table 1 PICO criteria for including studies
Population
Patients of at least 18 years of age, 
diagnosed with CKD, and formal and 
informal carers.
Intervention Experiences of healthcare provision, any 
type of treatment for CKD.
Comparator Not limited to comparator studies.
Outcomes Qualitative data on patients' and carers’ 
experiences of care for those patients with 
CKD.
Study type Primary studies, qualitative or mixed 
methods studies.
Time From 2000 to present.
CKD, chronic kidney disease; PICO, participants, interventions, 
comparators and outcomes. 
 o
n
 7 Septem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-023507 on 4 September 2018. Downloaded from 
3Roberti J, et al. BMJ Open 2018;8:e023507. doi:10.1136/bmjopen-2018-023507
Open access
two researchers (AC, MM). Refinement of the coding 
frame and analysis was iterative, codes were identified 
or merged reading the result sections of primary studies 
and consulting the theoretical framework. Investigator 
triangulation (comparison of results of two or more 
researchers) was used to capture relevant issues, reflect 
participants’ experience as reported and ensure the cred-
ibility of the findings.
Patient and public involvement
Patients and/or public were not involved in the devel-
opment of the research question. To ensure wide 
dissemination of this systematic review, it is published 
in peer-reviewed open-access journal and presented in 
research meetings.
rEsults
Combined searches yielded 5407 citations and resulted 
in 260 studies from 30 countries included in the final 
analysis. A total of 5115 patients and 1071 carers were 
included. Countries most frequently represented in the 
studies were: the USA with 52 (20%), the UK with 46 
(18%), Brazil with 28 (11%), Australia with 25 (10%), 
Canada with 20 (8%), Sweden with 19 (7%), New Zealand 
with 8 (3%) and Iran with 7 (3%) studies. Most studies 
(n=193, 74%) described the experiences of patients with 
ESKD, in dialysis or conservative treatment, 28 (11%) 
studies reported on transplanted patients, 17 (6%) 
studies referred to patients with CKD stages 1–4 and the 
remainder studies described experiences of patients with 
CKD in all stages. Table 2 shows characteristics of studies 
included in the review, box 1 shows illustrative quotations, 
table 3 shows summary of results and table 4 shows main 
challenges related to BoT.
structural inequalities
Access to care
Poverty and other socioeconomic disadvantages such as 
unemployment or poor housing conditions were defining 
factors for lack of treatment or interrupted care.37–52 
Living as a person with CKD and ESKD always implied 
some degree of financial burden, from having to pay for 
the whole dialysis treatment or transplantation surgery to 
out-of-pocket payments of incidentals, even in countries 
with universal coverage.35 47–49 51 53–63 Poorly funded or 
unfunded healthcare resulted in fragmented treatment 
across healthcare systems.47 48 64 Although patients who 
had difficulties affording treatment were naturally more 
concerned with accessing healthcare than in improving 
services, they recognised fragmentation and lack of inte-
gration as important problems.40 45 48–51 Where govern-
ment or private insurance coverage of ESKD treatment 
was limited, for example, Mexico or India, patients paid 
for some or all the following: vascular access, hospitalisa-
tion, medical visits, haemodialysis sessions, medication, 
tests, prescribed food, transport and meals.45 47–50 60 65 In 
such settings, patients received dialysis treatment only 
if they could afford it or when they had access to free 
sessions.45 47–50 60 65 Medication was sometimes counter-
feit, obtained on the black market, as legitimate medi-
cation was beyond patients’ reach.49 For the uninsured, 
dependence on emergency care added uncertainty and 
Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow chart of screening and selection 
process. CKD, chronic kidney disease.
 o
n
 7 Septem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-023507 on 4 September 2018. Downloaded from 
4 Roberti J, et al. BMJ Open 2018;8:e023507. doi:10.1136/bmjopen-2018-023507
Open access 
Ta
b
le
 2
 
C
ha
ra
ct
er
is
tic
s 
of
 in
cl
ud
ed
 s
tu
d
ie
s
A
ut
ho
r
Ye
ar
C
o
un
tr
y
S
et
ti
ng
P
at
ie
nt
s
C
ar
er
s
Ty
p
e 
o
f 
p
at
ie
nt
D
at
a 
co
lle
ct
io
n
D
at
a 
an
al
ys
is
 r
ep
o
rt
ed
A
as
en
 e
t 
al
10
7
20
12
N
or
w
ay
5 
H
, E
as
t,
 W
es
t
11
E
S
K
D
In
te
rv
ie
w
s
C
rit
ic
al
 d
is
co
ur
se
A
as
en
 e
t 
al
24
6
20
12
N
or
w
ay
5 
H
, E
as
t,
 W
es
t
7
E
S
K
D
In
te
rv
ie
w
s
C
rit
ic
al
 d
is
co
ur
se
A
as
en
28
7
20
12
N
or
w
ay
5 
H
, E
as
t,
 W
es
t
11
17
E
S
K
D
In
te
rv
ie
w
s
C
rit
ic
al
 d
is
co
ur
se
A
l-
A
ra
b
i1
04
20
06
U
S
A
1 
C
, S
ou
th
w
es
t
80
E
S
K
D
In
te
rv
ie
w
s
N
at
ur
al
is
tic
 in
q
ui
ry
, t
he
m
at
ic
A
lle
n 
et
 a
l1
73
20
11
C
an
ad
a
1 
H
, u
rb
an
7
E
S
K
D
E
th
no
gr
ap
hi
c 
ob
se
rv
at
io
ns
, 
in
te
rv
ie
w
s
P
ar
tic
ip
at
or
y 
ac
tio
n,
 t
he
m
at
ic
A
lle
n 
et
 a
l6
4
20
15
C
an
ad
a
2 
H
6
11
E
S
K
D
E
th
no
gr
ap
hi
c 
ob
se
rv
at
io
ns
, 
in
te
rv
ie
w
s
Th
em
at
ic
A
nd
er
so
n 
et
 a
l7
7
20
08
A
us
tr
al
ia
9 
H
, 1
7 
C
24
1
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
A
nd
er
so
n 
et
 a
l5
3
20
12
A
us
tr
al
ia
9 
H
, 1
7 
C
24
1
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
A
rs
la
n 
an
d
 E
ge
20
0
20
09
Tu
rk
ey
1 
H
, K
en
ya
10
E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
A
sh
b
y 
et
 a
l3
8
20
05
A
us
tr
al
ia
2 
H
, M
el
b
ou
rn
e
16
E
S
K
D
In
te
rv
ie
w
s
G
ro
un
d
ed
 t
he
or
y
A
vr
il-
S
ep
hu
la
 e
t 
al
11
8
20
14
U
K
1 
H
, N
or
th
8
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
A
xe
ls
so
n 
et
 a
l1
87
20
12
S
w
ed
en
2 
H
, 2
 C
8
E
S
K
D
In
te
rv
ie
w
s
P
he
no
m
en
ol
og
ic
al
, 
he
rm
en
eu
tic
al
A
xe
ls
so
n 
et
 a
l1
36
20
12
S
w
ed
en
2 
H
, 2
 C
8
E
S
K
D
In
te
rv
ie
w
s
P
he
no
m
en
ol
og
ic
al
, 
he
rm
en
eu
tic
al
A
xe
ls
so
n 
et
 a
l1
34
20
15
S
w
ed
en
2 
H
, 1
 C
, u
rb
an
14
E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
B
ai
le
y 
et
 a
l2
35
20
15
U
K
B
ris
to
l
32
Tr
an
sp
la
nt
ed
In
te
rv
ie
w
s
C
on
st
an
t 
co
m
p
ar
is
on
B
ai
le
y 
et
 a
l3
9
20
16
U
K
B
ris
to
l
13
Tr
an
sp
la
nt
ed
In
te
rv
ie
w
s
C
on
st
an
t 
co
m
p
ar
is
on
B
ai
lli
e 
an
d
 L
an
ks
he
ar
15
6
20
15
U
K
W
al
es
16
9
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
B
ai
lli
e 
an
d
 L
an
ks
he
ar
15
7
20
15
U
K
W
al
es
16
9
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
B
ar
b
os
a 
an
d
 V
al
ad
ar
es
14
5
20
09
B
ra
zi
l
1 
C
, R
io
 d
e 
Ja
ne
iro
10
E
S
K
D
In
te
rv
ie
w
s
G
ro
un
d
ed
 t
he
or
y
B
at
h 
et
 a
l2
52
20
03
U
K
S
ou
th
10
E
S
K
D
In
te
rv
ie
w
s
P
he
no
m
en
ol
og
ic
al
B
ea
nl
an
d
s 
et
 a
l2
10
20
05
C
an
ad
a
O
nt
ar
io
37
E
S
K
D
In
te
rv
ie
w
s
G
ro
un
d
ed
 t
he
or
y
B
en
ne
tt
 e
t 
al
19
7
20
13
A
us
tr
al
ia
4 
C
9
2
E
S
K
D
In
te
rv
ie
w
s 
fa
ci
lit
at
ed
 b
y 
im
ag
es
Th
em
at
ic
B
lo
gg
 a
nd
 H
yd
e6
9
20
08
A
us
tr
al
ia
U
rb
an
5
E
S
K
D
In
te
rv
ie
w
s
E
th
no
gr
ap
hi
c
B
oa
z 
an
d
 M
or
ga
n1
75
20
14
U
K
R
ur
al
, u
rb
an
25
Tr
an
sp
la
nt
ed
In
te
rv
ie
w
s
C
on
st
an
t 
co
m
p
ar
is
on
B
ou
rb
on
na
is
 a
nd
 
To
us
ig
na
nt
10
5
20
12
C
an
ad
a
1 
H
25
E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
C
on
tin
ue
d
 o
n
 7 Septem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-023507 on 4 September 2018. Downloaded from 
5Roberti J, et al. BMJ Open 2018;8:e023507. doi:10.1136/bmjopen-2018-023507
Open access
A
ut
ho
r
Ye
ar
C
o
un
tr
y
S
et
ti
ng
P
at
ie
nt
s
C
ar
er
s
Ty
p
e 
o
f 
p
at
ie
nt
D
at
a 
co
lle
ct
io
n
D
at
a 
an
al
ys
is
 r
ep
o
rt
ed
B
rid
ge
r2
38
20
09
U
K
G
P,
 S
ou
th
23
C
K
D
In
te
rv
ie
w
s,
 
d
ra
w
in
gs
, j
ou
rn
al
s
G
ro
un
d
ed
 t
he
or
y
B
ris
to
w
e 
et
 a
l1
26
20
15
U
K
2 
C
, L
on
d
on
20
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
d
e 
B
rit
o-
A
sh
ur
st
 e
t 
al
12
1
20
11
U
K
Lo
nd
on
20
C
K
D
Fo
cu
s 
gr
ou
p
s,
 
vi
gn
et
te
s 
an
d
 
d
ia
rie
s
Th
em
at
ic
B
ro
w
ne
 e
t 
al
22
6
20
16
U
S
A
S
ou
th
40
E
S
K
D
Fo
cu
s 
gr
ou
p
s
C
on
te
nt
B
ul
d
uk
og
lu
 e
t 
al
18
6
20
05
Tu
rk
ey
A
nt
al
ya
40
Tr
an
sp
la
nt
ed
O
p
en
-e
nd
ed
 
q
ue
st
io
ns
C
on
st
an
t 
co
m
p
ar
is
on
B
ur
ne
tt
e 
an
d
 K
ic
ke
tt
78
20
09
A
us
tr
al
ia
1 
C
, P
er
th
6
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
C
ad
en
a 
et
 a
l1
54
20
15
M
ex
ic
o
C
oy
ot
ep
ec
, M
ex
ic
o
5
E
S
K
D
In
te
rv
ie
w
s
In
te
rp
re
ta
tiv
e 
p
he
no
m
en
ol
og
ic
al
C
al
ve
y 
an
d
 M
ee
14
6
20
11
Ire
la
nd
N
A
7
E
S
K
D
In
te
rv
ie
w
s
C
ol
ai
zz
i's
 m
et
ho
d
C
al
vi
nl
25
1
20
04
U
S
A
3 
C
, T
ex
as
12
E
S
K
D
In
te
rv
ie
w
s
C
on
st
an
t 
co
m
p
ar
is
on
C
al
vi
n 
et
 a
l2
92
20
14
U
S
A
Te
xa
s
18
E
S
K
D
In
te
rv
ie
w
s
In
te
rp
re
ta
tiv
e,
 G
la
se
ria
n
C
am
p
os
 a
nd
 T
ur
at
o2
34
20
03
B
ra
zi
l
1 
H
, S
ao
 P
au
lo
7
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
C
am
p
os
 a
nd
 T
ur
at
o8
7
20
10
B
ra
zi
l
1 
H
, S
ao
 P
au
lo
7
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
C
am
p
os
 e
t 
al
88
20
15
B
ra
zi
l
H
, C
, P
ar
an
á
23
E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
C
as
es
 e
t 
al
27
9
20
11
U
K
N
A
6
E
S
K
D
In
te
rv
ie
w
s
P
he
no
m
en
ol
og
ic
al
C
er
va
nt
es
 e
t 
al
52
20
17
U
S
A
1 
H
, C
ol
or
ad
o
20
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
C
ha
tr
un
g 
et
 a
l1
88
20
15
U
S
A
C
al
ifo
rn
ia
8
C
K
D
In
te
rv
ie
w
s
Th
em
at
ic
C
he
ni
tz
 e
t 
al
86
20
14
U
S
A
4 
C
, P
en
ns
yl
va
ni
a
30
E
S
K
D
In
te
rv
ie
w
s
G
ro
un
d
ed
 t
he
or
y
C
hi
ar
an
ai
40
20
16
Th
ai
la
nd
1 
H
26
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
C
ho
 a
nd
 S
hi
n4
1
20
16
S
ou
th
 K
or
ea
1 
H
, S
ou
th
5
E
S
K
D
In
te
rv
ie
w
s
C
ol
ai
zz
i's
 m
et
ho
d
C
ho
ng
 e
t 
al
16
4
20
16
S
ou
th
 K
or
ea
1 
H
, S
ou
th
8
E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
C
la
rk
so
n 
an
d
 R
ob
in
so
n1
06
20
10
U
S
A
O
kl
ah
om
a
10
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
C
os
ta
 e
t 
al
19
8
20
14
B
ra
zi
l
3 
H
, P
ar
aí
b
a
26
E
S
K
D
In
te
rv
ie
w
s
Le
xi
ca
l
C
os
ta
nt
in
i e
t 
al
92
20
08
C
an
ad
a
O
nt
ar
io
14
C
K
D
In
te
rv
ie
w
s
C
on
te
nt
C
ox
 e
t 
al
14
8
20
16
U
S
A
6 
C
, N
ew
 M
ex
ic
o
50
E
S
K
D
In
te
rv
ie
w
s
In
te
rp
re
tiv
e 
d
es
cr
ip
tio
n
C
ra
m
m
 e
t 
al
21
9
20
15
Th
e 
N
et
he
rla
nd
s
1 
H
, R
ot
te
rd
am
15
12
E
S
K
D
In
te
rv
ie
w
s
Fa
ct
or
 a
na
ly
si
s,
 Q
 m
et
ho
d
ol
og
y
C
ris
tó
va
o 
et
 a
l1
13
20
13
P
or
tu
ga
l
1 
C
, L
is
b
on
20
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
C
ro
w
le
y-
M
at
ok
a 
et
 a
l8
3
20
05
M
ex
ic
o
2 
p
ro
g,
 G
ua
d
al
aj
ar
a
50
Tr
an
sp
la
nt
ed
In
te
rv
ie
w
s
N
A
C
ur
tin
 e
t 
al
26
5
20
01
U
S
A
D
iv
er
se
18
E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
Ta
b
le
 2
 
C
on
tin
ue
d
 
C
on
tin
ue
d
 o
n
 7 Septem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-023507 on 4 September 2018. Downloaded from 
6 Roberti J, et al. BMJ Open 2018;8:e023507. doi:10.1136/bmjopen-2018-023507
Open access 
A
ut
ho
r
Ye
ar
C
o
un
tr
y
S
et
ti
ng
P
at
ie
nt
s
C
ar
er
s
Ty
p
e 
o
f 
p
at
ie
nt
D
at
a 
co
lle
ct
io
n
D
at
a 
an
al
ys
is
 r
ep
o
rt
ed
C
ur
tin
 e
t 
al
26
4
20
02
U
S
A
18
E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
d
a 
S
ilv
a 
et
 a
l1
03
20
16
B
ra
zi
l
1 
C
, N
or
th
ea
st
30
E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
 a
nd
 t
he
m
at
ic
d
a 
S
ilv
a 
et
 a
l3
38
20
11
B
ra
zi
l
1 
H
, R
io
 G
ra
nd
e 
d
o 
S
ul
9
E
S
K
D
In
te
rv
ie
w
s
Q
ua
lit
at
iv
e
D
ar
re
ll 
et
 a
l2
81
20
16
U
S
A
1 
H
12
E
S
K
D
In
te
rv
ie
w
s
G
io
rg
i's
 m
et
ho
d
D
av
is
on
 e
t 
al
23
1
20
06
C
an
ad
a
A
lb
er
ta
24
E
S
K
D
In
te
rv
ie
w
s
C
on
st
an
t 
co
m
p
ar
is
on
, i
te
ra
tiv
e
D
av
is
on
 e
t 
al
29
1
20
06
C
an
ad
a
1 
H
19
E
S
K
D
In
te
rv
ie
w
s
in
d
uc
tiv
e
d
e 
B
rit
o 
et
 a
l8
9
20
15
B
ra
zi
l
1 
H
, M
in
as
 G
er
ai
s
50
Tr
an
sp
la
nt
ed
In
te
rv
ie
w
s
C
ol
le
ct
iv
e 
su
b
je
ct
 t
ec
hn
iq
ue
d
e 
R
os
en
ro
ll 
et
 a
l2
77
20
13
C
an
ad
a
1 
H
10
E
S
K
D
In
te
rv
ie
w
s
C
on
st
an
t 
co
m
p
ar
is
on
D
ek
ke
rs
 e
t 
al
42
20
05
Th
e 
N
et
he
rla
nd
s
2 
C
7
E
S
K
D
In
te
rv
ie
w
s
P
he
no
m
en
ol
og
ic
al
D
eP
as
q
ua
le
 e
t 
al
22
1
20
13
U
S
A
N
P,
 1
 C
68
62
C
K
D
G
ro
up
 in
te
rv
ie
w
s
M
ix
ed
 m
et
ho
d
d
os
 R
ei
s 
et
 a
l1
55
20
08
B
ra
zi
l
1 
H
, S
ao
 P
au
lo
8
E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
d
os
 S
an
to
s 
et
 a
l1
62
20
11
B
ra
zi
l
R
io
 d
e 
Ja
ne
iro
8
E
S
K
D
In
te
rv
ie
w
s
G
ro
un
d
ed
 t
he
or
y
d
os
 S
an
to
s 
et
 a
l2
59
20
15
B
ra
zi
l
3 
N
P,
 R
io
 G
ra
nd
e 
d
o 
S
ul
20
Tr
an
sp
la
nt
ed
In
te
rv
ie
w
s
C
rit
ic
al
 in
ci
d
en
t
E
ke
lu
nd
 e
t 
al
43
20
10
S
w
ed
en
1 
C
, S
ou
th
39
21
E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
E
rla
ng
 e
t 
al
20
3
20
15
D
en
m
ar
k
1 
H
9
C
K
D
 (p
re
d
ia
ly
si
s)
In
te
rv
ie
w
s
S
ys
te
m
at
ic
 t
ex
t 
co
nd
en
sa
tio
n
E
sl
am
i e
t 
al
21
4
20
16
Ir
an
4 
C
, I
sf
ah
an
20
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
Fi
nn
eg
an
-J
oh
n 
et
 a
l9
0
20
13
U
K
1 
tr
us
t,
 L
on
d
on
11
8
12
C
K
D
/E
S
K
D
In
te
rv
ie
w
s 
an
d
 
fo
cu
s 
gr
ou
p
s
Th
em
at
ic
Fl
or
es
 e
t 
al
16
5
20
04
B
ra
zi
l
1 
H
, R
io
 G
ra
nd
e 
d
o 
S
ul
9
E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
Fr
ag
ua
s 
et
 a
l3
7
20
08
B
ra
zi
l
2 
H
, M
in
as
 G
er
ai
s
18
E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
G
ha
d
am
i e
t 
al
23
9
20
12
Ir
an
1 
ch
ar
ity
, I
sf
ah
an
15
Tr
an
sp
la
nt
ed
In
te
rv
ie
w
s
C
on
te
nt
G
ile
s 
et
 a
l1
59
20
03
C
an
ad
a
1 
H
, u
rb
an
4
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
G
ile
s 
et
 a
l1
60
20
05
C
an
ad
a
4
E
S
K
D
In
te
rv
ie
w
s
P
he
no
m
en
ol
og
ic
al
G
of
f e
t 
al
28
8
20
15
U
S
A
N
ew
 M
ex
ic
o
13
9
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
G
ol
d
an
e 
et
 a
l1
76
20
11
U
S
A
1 
C
39
Tr
an
sp
la
nt
ed
Fo
cu
s 
gr
ou
p
s 
an
d
 
in
te
rv
ie
w
s
Ite
ra
tiv
e 
an
al
ys
is
G
or
d
on
 e
t 
al
18
0
20
07
U
S
A
20
Tr
an
sp
la
nt
ed
D
ia
ry
 e
nt
rie
s
Th
em
at
ic
G
or
d
on
 e
t 
al
84
20
09
U
S
A
2 
H
, I
lli
no
is
, N
ew
 
Yo
rk
82
Tr
an
sp
la
nt
ed
In
te
rv
ie
w
s
Th
em
at
ic
G
ric
io
 e
t 
al
11
4
20
09
B
ra
zi
l
1 
H
, S
ao
 P
au
lo
20
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
Ta
b
le
 2
 
C
on
tin
ue
d
 
C
on
tin
ue
d
 o
n
 7 Septem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-023507 on 4 September 2018. Downloaded from 
7Roberti J, et al. BMJ Open 2018;8:e023507. doi:10.1136/bmjopen-2018-023507
Open access
A
ut
ho
r
Ye
ar
C
o
un
tr
y
S
et
ti
ng
P
at
ie
nt
s
C
ar
er
s
Ty
p
e 
o
f 
p
at
ie
nt
D
at
a 
co
lle
ct
io
n
D
at
a 
an
al
ys
is
 r
ep
o
rt
ed
G
ul
lic
k 
et
 a
l3
39
20
16
A
us
tr
al
ia
1 
H
, S
yd
ne
y
11
5
E
S
K
D
In
te
rv
ie
w
s
H
er
m
en
eu
tic
 in
te
rp
re
ta
tio
n
H
ag
re
n 
et
 a
l2
82
20
01
S
w
ed
en
1 
H
15
E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
H
ag
re
n 
et
 a
l1
15
20
05
S
w
ed
en
3 
H
41
E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
H
ai
n 
et
 a
l1
89
20
11
U
S
A
6 
C
, S
ou
th
ea
st
56
E
S
K
D
In
te
rv
ie
w
s
S
to
ry
 in
q
ui
ry
 m
et
ho
d
H
an
so
n 
et
 a
l7
0
20
16
A
us
tr
al
ia
1 
C
, W
es
t
20
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
H
ar
rin
gt
on
 e
t 
al
28
3
20
16
U
K
8 
H
24
Tr
an
sp
la
nt
ed
In
te
rv
ie
w
s
Th
em
at
ic
H
ar
w
oo
d
 e
t 
al
27
0
20
14
C
an
ad
a
1 
H
13
E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
H
ar
w
oo
d
 e
t 
al
24
8
20
05
U
K
1 
H
, L
on
d
on
11
C
K
D
/E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
H
as
p
es
la
gh
 e
t 
al
24
0
20
13
B
el
gi
um
1 
H
, L
eu
ve
n
31
Tr
an
sp
la
nt
ed
In
te
rv
ie
w
s 
an
d
 
q
ue
st
io
nn
ai
re
s
Th
em
at
ic
H
ei
w
e 
et
 a
l1
37
20
03
S
w
ed
en
1 
H
, K
ar
ol
in
sk
a
16
E
S
K
D
In
te
rv
ie
w
s
C
on
te
xt
ua
l
H
ei
w
e 
et
 a
l1
40
20
04
S
w
ed
en
1 
H
, K
ar
ol
in
sk
a
16
C
K
D
/E
S
K
D
In
te
rv
ie
w
s
C
on
te
xt
ua
l
H
er
b
ia
s 
et
 a
l1
16
20
16
C
hi
le
1 
C
, S
an
tia
go
12
E
S
K
D
In
te
rv
ie
w
s
S
tr
eu
b
er
t'
s 
m
et
ho
d
H
er
lin
 e
t 
al
28
4
20
10
S
w
ed
en
3 
C
9
E
S
K
D
In
te
rv
ie
w
s
G
io
rg
i's
 m
et
ho
d
H
ol
lin
gd
al
e 
et
 a
l2
27
20
08
U
K
20
C
K
D
/E
S
K
D
Fo
cu
s 
gr
ou
p
s
Fr
am
ew
or
k 
ap
p
ro
ac
h
H
on
g 
et
 a
l1
20
20
17
S
in
ga
p
or
e
1 
H
14
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
H
or
ig
an
 e
t 
al
13
8
20
13
U
S
A
1 
C
, M
id
-A
tla
nt
ic
14
E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
H
ut
ch
is
on
 e
t 
al
29
0
20
17
C
an
ad
a
1 
cl
in
ic
, u
rb
an
9
16
C
K
D
/E
S
K
D
In
te
rv
ie
w
s
In
te
rp
re
tiv
e 
d
es
cr
ip
tio
n
Ile
s-
S
m
ith
 e
t 
al
23
2
20
05
U
K
1 
C
, M
an
ch
es
te
r
10
C
K
D
 (p
re
d
ia
ly
si
s)
In
te
rv
ie
w
s
Th
em
at
ic
Jo
hn
st
on
 e
t 
al
12
8
20
12
U
K
1 
tr
us
t,
 L
on
d
on
9
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
K
ab
a 
et
 a
l3
40
20
07
G
re
ec
e
2 
H
, A
th
en
s
23
E
S
K
D
In
te
rv
ie
w
s
Q
ua
lit
at
iv
e
K
ah
n 
et
 a
l3
5
20
15
U
S
A
2 
N
P,
 N
ew
 Y
or
k
34
C
K
D
In
te
rv
ie
w
s
Th
em
at
ic
K
ar
am
an
id
ou
 e
t 
al
15
20
14
U
K
1 
C
, L
on
d
on
7
E
S
K
D
In
te
rv
ie
w
s
In
te
rp
re
ta
tiv
e,
 p
he
no
m
en
ol
og
ic
al
K
az
le
y 
et
 a
l4
4
20
15
U
S
A
1 
C
, S
ou
th
ea
st
20
C
K
D
/E
S
K
D
Fo
cu
s 
gr
ou
p
s
Th
em
at
ic
K
ee
p
in
g 
et
 a
l7
3
20
01
C
an
ad
a
E
as
t
8
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
K
ie
ra
ns
 e
t 
al
16
7
20
01
Ire
la
nd
5
E
S
K
D
In
te
rv
ie
w
s,
 li
fe
 
st
or
ie
s
P
he
no
m
en
ol
og
ic
al
K
ie
ra
ns
 e
t 
al
16
6
20
05
Ire
la
nd
5
C
K
D
/E
S
K
D
In
te
rv
ie
w
s
P
he
no
m
en
ol
og
ic
al
K
ie
ra
ns
 e
t 
al
12
5
20
13
M
ex
ic
o
1 
H
, J
al
is
co
51
87
C
K
D
/E
S
K
D
, 
tr
an
sp
la
nt
ed
In
te
rv
ie
w
s,
 
ob
se
rv
at
io
n*
E
th
no
gr
ap
hi
c 
ap
p
ro
ac
h
K
in
g 
et
 a
l9
1
20
02
U
K
1 
C
22
C
K
D
/E
S
K
D
In
te
rv
ie
w
s
Te
m
p
la
te
 a
p
p
ro
ac
h
K
ni
hs
 e
t 
al
16
8
20
13
B
ra
zi
l
1 
C
, S
ou
th
20
E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
K
re
sp
i-
B
oo
th
b
y 
et
 a
l1
47
20
04
U
K
1 
H
, 4
 C
16
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
Ta
b
le
 2
 
C
on
tin
ue
d
 
C
on
tin
ue
d
 o
n
 7 Septem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-023507 on 4 September 2018. Downloaded from 
8 Roberti J, et al. BMJ Open 2018;8:e023507. doi:10.1136/bmjopen-2018-023507
Open access 
A
ut
ho
r
Ye
ar
C
o
un
tr
y
S
et
ti
ng
P
at
ie
nt
s
C
ar
er
s
Ty
p
e 
o
f 
p
at
ie
nt
D
at
a 
co
lle
ct
io
n
D
at
a 
an
al
ys
is
 r
ep
o
rt
ed
K
re
sp
i-
B
oo
th
b
y 
et
 a
l1
51
20
13
U
K
1 
H
, 4
 C
16
E
S
K
D
In
te
rv
ie
w
s
Te
m
p
la
te
 a
p
p
ro
ac
h
La
d
in
 e
t 
al
20
2
20
16
U
S
A
2 
C
, M
as
sa
ch
us
et
ts
23
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
La
d
in
 e
t 
al
26
9
20
17
U
S
A
2 
C
, M
as
sa
ch
us
et
ts
31
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
 N
ut
b
ea
m
’s
 fr
am
ew
or
k
La
nd
re
ne
au
 e
t 
al
27
4
20
06
U
S
A
1 
C
, 1
 N
P,
 S
ou
th
6
E
S
K
D
In
te
rv
ie
w
s
C
ol
ai
zz
i's
 m
et
ho
d
La
nd
re
ne
au
 e
t 
al
27
8
20
07
U
S
A
2 
C
, S
ou
th
12
E
S
K
D
In
te
rv
ie
w
s
C
ol
ai
zz
i's
 m
et
ho
d
La
w
re
nc
e 
et
 a
l1
69
20
13
U
K
1 
C
10
E
S
K
D
In
te
rv
ie
w
s
C
on
ce
p
tu
al
 a
nd
 c
at
eg
or
ic
al
Le
d
er
er
 e
t 
al
26
6
20
15
U
S
A
1 
C
32
C
K
D
/E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
Le
e 
et
 a
l2
23
20
08
D
en
m
ar
k
D
iv
er
se
27
18
E
S
K
D
Fo
cu
s 
gr
ou
p
s
Th
em
at
ic
Le
e 
et
 a
l4
5
20
16
S
in
ga
p
or
e
1 
or
ga
ni
sa
tio
n
20
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
Le
nc
i e
t 
al
25
6
20
12
U
S
A
4
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
Le
un
g 
et
 a
l1
81
20
07
H
on
g 
K
on
g
1 
C
12
Tr
an
sp
la
nt
ed
In
te
rv
ie
w
s
C
on
te
nt
Le
w
is
 e
t 
al
28
5
20
15
U
K
14
 H
40
E
S
K
D
In
te
rv
ie
w
s
G
ro
un
d
ed
 t
he
or
y
Li
n 
et
 a
l1
90
20
15
Ta
iw
an
1 
C
, S
, r
ur
al
15
E
S
K
D
In
te
rv
ie
w
s
C
on
st
an
t 
co
m
p
ar
is
on
Li
nd
b
er
g 
et
 a
l4
6
20
08
S
w
ed
en
1 
C
, m
id
-c
ou
nt
ry
10
E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
Li
nd
b
er
g 
et
 a
l2
62
20
13
S
w
ed
en
1 
C
, m
id
-c
ou
nt
ry
10
E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
Li
nd
sa
y 
et
 a
l2
80
20
14
A
us
tr
al
ia
1 
C
, S
yd
ne
y
7
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
Ll
ew
el
ly
n 
et
 a
l2
71
20
14
U
K
4 
C
, L
on
d
on
19
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
Lo
 e
t 
al
12
9
20
16
A
us
tr
al
ia
4 
H
, M
el
b
ou
rn
e,
 
S
yd
ne
y
58
C
K
D
/E
S
K
D
In
te
rv
ie
w
s 
an
d
 
fo
cu
s 
gr
ou
p
s
Th
em
at
ic
Lo
p
es
 e
t 
al
17
0
20
14
B
ra
zi
l
1 
C
, S
an
ta
 C
at
ar
in
a
12
E
S
K
D
In
te
rv
ie
w
s
In
te
rp
re
ta
tiv
e
Lo
p
ez
-V
ar
ga
s 
et
 a
l9
4
20
14
A
us
tr
al
ia
3 
C
, N
ew
 S
ou
th
 
W
al
es
38
C
K
D
Fo
cu
s 
gr
ou
p
s
Th
em
at
ic
Lo
p
ez
-V
ar
ga
s 
et
 a
l9
3
20
16
A
us
tr
al
ia
3 
C
, N
ew
 S
ou
th
 
W
al
es
38
C
K
D
/E
S
K
D
Fo
cu
s 
gr
ou
p
s
Th
em
at
ic
Lo
vi
nk
 e
t 
al
21
7
20
15
Th
e 
N
et
he
rla
nd
s
1 
C
12
E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
Lo
w
 e
t 
al
16
1
20
14
U
K
5 
C
, S
ou
th
ea
st
26
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
M
ac
ha
d
o 
et
 a
l1
49
20
03
B
ra
zi
l
S
ao
 P
au
lo
18
E
S
K
D
In
te
rv
ie
w
s
D
is
co
ur
se
M
ar
q
ue
s 
et
 a
l2
28
20
14
B
ra
zi
l
P
ar
an
á
10
E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
M
ar
tin
-M
cD
on
al
d
 e
t 
al
19
4
20
03
A
us
tr
al
ia
5 
C
10
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
M
ar
tin
-M
cD
on
al
d
 e
t 
al
19
5
20
03
A
us
tr
al
ia
1 
C
10
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
M
as
on
 e
t 
al
95
20
07
U
K
1 
C
9
5
C
K
D
Fo
cu
s 
gr
ou
p
s
Fr
am
ew
or
k 
ap
p
ro
ac
h
M
cC
ar
th
y 
et
 a
l1
63
20
10
A
us
tr
al
ia
1 
H
5
E
S
K
D
In
te
rv
ie
w
s
S
eq
ue
nt
ia
l
Ta
b
le
 2
 
C
on
tin
ue
d
 
C
on
tin
ue
d
 o
n
 7 Septem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-023507 on 4 September 2018. Downloaded from 
9Roberti J, et al. BMJ Open 2018;8:e023507. doi:10.1136/bmjopen-2018-023507
Open access
A
ut
ho
r
Ye
ar
C
o
un
tr
y
S
et
ti
ng
P
at
ie
nt
s
C
ar
er
s
Ty
p
e 
o
f 
p
at
ie
nt
D
at
a 
co
lle
ct
io
n
D
at
a 
an
al
ys
is
 r
ep
o
rt
ed
M
cK
ill
op
 e
t 
al
26
7
20
13
U
K
C
lin
ic
s
10
C
K
D
In
te
rv
ie
w
s
Th
em
at
ic
M
er
ca
d
o-
M
ar
tín
ez
 e
t 
al
49
20
14
M
ex
ic
o
Ja
lis
co
, S
an
 L
ui
s 
P
ot
os
í
21
Tr
an
sp
la
nt
ed
In
te
rv
ie
w
s
Th
em
at
ic
M
er
ca
d
o-
M
ar
tín
ez
 e
t 
al
48
20
15
B
ra
zi
l
1 
H
, S
ou
th
11
5
E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
M
er
ca
d
o-
M
ar
tín
ez
 e
t 
al
47
20
15
M
ex
ic
o
P
ub
lic
 H
 a
nd
 
in
st
itu
tio
ns
, J
al
is
co
37
50
E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
M
itc
he
ll 
et
 a
l2
05
20
09
U
K
1 
C
10
C
K
D
/E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
M
ol
za
hn
 e
t 
al
29
4
20
12
C
an
ad
a
M
id
d
le
 s
iz
e 
ci
ty
14
C
K
D
In
te
rv
ie
w
s
Th
em
at
ic
M
or
an
 e
t 
al
20
4
20
09
Ire
la
nd
1 
H
16
E
S
K
D
In
te
rv
ie
w
s
In
te
rp
re
tiv
e
M
or
an
 e
t 
al
15
0
20
09
Ire
la
nd
1 
H
16
E
S
K
D
In
te
rv
ie
w
s
In
te
rp
re
tiv
e
M
or
an
 e
t 
al
13
3
20
11
Ire
la
nd
H
16
E
S
K
D
In
te
rv
ie
w
s
In
te
rp
re
ta
tiv
e
M
or
to
n 
et
 a
l7
9
20
10
A
us
tr
al
ia
D
iv
er
se
95
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
M
ud
um
a 
et
 a
l9
6
20
16
U
K
2 
C
37
Tr
an
sp
la
nt
ed
Fo
cu
s 
gr
ou
p
s
Q
ua
lit
at
iv
e
N
ag
p
al
 e
t 
al
21
8
20
17
U
S
A
1 
C
, N
ew
 Y
or
k
36
E
S
K
D
In
te
rv
ie
w
s
C
od
in
g
N
am
ik
i e
t 
al
22
0
20
10
A
us
tr
al
ia
1 
H
4
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
N
iu
 e
t 
al
19
6
20
17
C
hi
na
1 
C
, J
ia
ng
su
23
E
S
K
D
In
te
rv
ie
w
s
C
on
tin
uo
us
 c
om
p
ar
is
on
N
ob
ah
ar
 e
t 
al
67
20
16
Ir
an
1 
H
, S
em
na
n
8
12
E
S
K
D
In
te
rv
ie
w
s
G
ra
ne
he
im
 L
un
d
m
an
 c
on
te
nt
N
ob
ah
ar
 e
t 
al
68
20
16
Ir
an
1 
H
, S
em
na
n
8
12
E
S
K
D
In
te
rv
ie
w
s
G
ra
nh
ei
m
 a
nd
 L
un
d
m
an
's
 
ap
p
ro
ac
h
N
ob
le
 e
t 
al
29
3
20
09
U
K
1 
se
rv
ic
e,
 L
on
d
on
30
17
E
S
K
D
In
te
rv
ie
w
s
C
on
st
an
t 
co
m
p
ar
is
on
N
ob
le
 e
t 
al
98
20
10
U
K
1 
se
rv
ic
e,
 L
on
d
on
30
17
E
S
K
D
In
te
rv
ie
w
s
C
on
st
an
t 
co
m
p
ar
is
on
N
ob
le
 e
t 
al
97
20
12
U
K
1 
se
rv
ic
e
19
E
S
K
D
In
te
rv
ie
w
s
C
on
st
an
t 
co
m
p
ar
is
on
N
yg
ar
d
h 
et
 a
l2
89
20
11
S
w
ed
en
1 
C
, S
ou
th
12
C
K
D
 (p
re
d
ia
ly
si
s)
In
te
rv
ie
w
s
C
on
te
nt
N
yg
ar
d
h 
et
 a
l2
36
20
11
S
w
ed
en
1 
C
, S
ou
th
20
C
K
D
In
te
rv
ie
w
s
La
te
nt
 c
on
te
nt
M
al
he
iro
 O
liv
ei
ra
 e
t 
al
20
9
20
12
B
ra
zi
l
B
ah
ia
19
E
S
K
D
In
te
rv
ie
w
s
C
at
eg
or
ic
al
O
rr
 e
t 
al
18
2
20
07
U
K
1 
C
26
Tr
an
sp
la
nt
ed
Fo
cu
s 
gr
ou
p
s
Th
em
at
ic
O
rr
 e
t 
al
18
3
20
07
U
K
1 
C
26
Tr
an
sp
la
nt
ed
Fo
cu
s 
gr
ou
p
s
Th
em
at
ic
O
ye
gb
ile
 e
t 
al
65
20
16
N
ig
er
ia
2 
H
, S
ou
th
w
es
t
15
E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
P
el
le
tie
r-
H
ib
b
er
t 
et
 a
l2
86
20
01
C
an
ad
a
E
as
t
41
E
S
K
D
Fo
cu
s 
gr
ou
p
s
Th
em
at
ic
P
ic
co
li 
et
 a
l2
24
20
10
Ita
ly
1 
H
12
C
K
D
/E
S
K
D
, 
tr
an
sp
la
nt
ed
Fo
cu
s 
gr
ou
p
s
N
ot
 c
le
ar
P
ie
tr
ov
sk
i e
t 
al
20
8
20
06
B
ra
zi
l
1 
H
, P
ar
an
á
15
E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
P
ilg
er
 e
t 
al
22
5
20
10
B
ra
zi
l
1 
C
, P
ar
an
á
22
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
Ta
b
le
 2
 
C
on
tin
ue
d
 
C
on
tin
ue
d
 o
n
 7 Septem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-023507 on 4 September 2018. Downloaded from 
10 Roberti J, et al. BMJ Open 2018;8:e023507. doi:10.1136/bmjopen-2018-023507
Open access 
A
ut
ho
r
Ye
ar
C
o
un
tr
y
S
et
ti
ng
P
at
ie
nt
s
C
ar
er
s
Ty
p
e 
o
f 
p
at
ie
nt
D
at
a 
co
lle
ct
io
n
D
at
a 
an
al
ys
is
 r
ep
o
rt
ed
P
ol
as
ch
ek
 e
t 
al
54
20
03
N
ew
 Z
ea
la
nd
1 
C
6
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
P
ol
as
ch
ek
 e
t 
al
55
20
06
N
ew
 Z
ea
la
nd
1 
re
gi
on
al
 
d
ep
ar
tm
en
t
20
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
P
ol
as
ch
ek
 e
t 
al
56
20
07
N
ew
 Z
ea
la
nd
1 
re
gi
on
al
 
d
ep
ar
tm
en
t
20
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
P
rie
to
 e
t 
al
13
0
20
11
S
p
ai
n
A
nd
al
us
ia
22
E
S
K
D
In
te
rv
ie
w
s
D
is
co
ur
se
R
ab
ie
i e
t 
al
14
1
20
15
Ir
an
Is
fa
ha
n
20
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
R
av
en
sc
ro
ft
 e
t 
al
26
0
20
05
C
an
ad
a
3 
C
7
E
S
K
D
In
te
rv
ie
w
s
In
d
uc
tiv
e
R
ei
d
 e
t 
al
26
8
20
12
U
K
1 
C
, c
lin
ic
s
11
C
K
D
/E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
R
et
a 
et
 a
l1
31
20
14
S
p
ai
n
1 
H
, A
ra
b
a
14
E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
R
ic
ha
rd
 e
t 
al
10
8
20
10
U
S
A
14
E
S
K
D
In
te
rv
ie
w
s
C
ul
tu
ra
l n
eg
ot
ia
tio
n 
m
od
el
 
fr
am
ew
or
k
R
ifk
in
 e
t 
al
99
20
10
U
S
A
1 
C
20
C
K
D
/E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
R
ix
 e
t 
al
58
20
14
A
us
tr
al
ia
N
ew
 S
ou
th
 W
al
es
, 
ru
ra
l
18
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
R
ix
 e
t 
al
57
20
15
A
us
tr
al
ia
N
ew
 S
ou
th
 W
al
es
, 
ru
ra
l
18
29
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
R
od
rig
ue
s 
et
 a
l1
91
20
11
B
ra
zi
l
1 
C
, S
ou
th
8
E
S
K
D
In
te
rv
ie
w
s
C
at
eg
or
ic
al
R
os
 e
t 
al
24
4
20
12
U
S
A
1 
H
, M
ar
yl
an
d
19
E
S
K
D
Fo
cu
s 
gr
ou
p
s
Th
em
at
ic
R
os
o 
et
 a
l1
19
20
13
B
ra
zi
l
1 
H
, S
ou
th
15
E
S
K
D
N
ar
ra
tiv
e 
in
te
rv
ie
w
s
Th
em
at
ic
R
us
s 
et
 a
l2
29
20
05
U
S
A
2 
C
, C
al
ifo
rn
ia
43
E
S
K
D
In
te
rv
ie
w
s
A
nt
hr
op
ol
og
ic
 s
tu
d
y
R
us
se
ll 
et
 a
l2
41
20
03
U
S
A
1 
C
, M
id
w
es
t
16
Tr
an
sp
la
nt
ed
In
te
rv
ie
w
s
C
on
st
an
t 
co
m
p
ar
is
on
R
yg
h 
et
 a
l7
1
20
12
N
or
w
ay
N
or
th
11
E
S
K
D
In
te
rv
ie
w
s
In
d
uc
tiv
e,
 a
ct
or
's
 p
oi
nt
 o
f v
ie
w
S
ad
al
a 
et
 a
l7
2
20
12
B
ra
zi
l
1 
H
19
E
S
K
D
N
ar
ra
tiv
e 
in
te
rv
ie
w
s
P
he
no
m
en
ol
og
ic
al
, 
he
rm
en
eu
tic
al
S
ah
af
 e
t 
al
22
2
20
17
Ir
an
2 
ho
ur
, S
ar
i
9
E
S
K
D
In
te
rv
ie
w
s
va
n 
M
an
en
's
 t
he
m
at
ic
S
al
va
la
gg
io
 e
t 
al
82
20
03
C
an
ad
a
1 
H
, O
nt
ar
io
12
E
S
K
D
In
te
rv
ie
w
s
Im
m
er
si
on
/c
ry
st
al
is
at
io
n
S
ch
el
l e
t 
al
27
2
20
12
U
S
A
1 
un
iv
er
si
ty
 s
ys
te
m
, 
1 
N
P,
 N
or
th
 C
ar
ol
in
a
29
11
C
K
D
/E
S
K
D
In
te
rv
ie
w
s 
an
d
 
fo
cu
s 
gr
ou
p
s
Th
em
at
ic
S
ch
ip
p
er
 e
t 
al
18
4
20
14
Th
e 
N
et
he
rla
nd
s
5 
H
30
Tr
an
sp
la
nt
ed
Fo
cu
s 
gr
ou
p
s 
an
d
 
in
te
rv
ie
w
s
Th
em
at
ic
S
ch
m
id
-M
oh
le
r 
et
 a
l8
5
20
14
S
w
itz
er
la
nd
1 
H
, Z
ur
ic
h
12
Tr
an
sp
la
nt
ed
In
te
rv
ie
w
s
C
on
te
nt
S
ch
ob
er
 e
t 
al
20
6
20
16
U
S
A
14
 s
ta
te
s
48
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
S
ea
h 
et
 a
l5
0
20
13
S
in
ga
p
or
e
3 
H
9
E
S
K
D
In
te
rv
ie
w
s
In
te
rp
re
ta
tiv
e 
p
he
no
m
en
ol
og
ic
al
Ta
b
le
 2
 
C
on
tin
ue
d
 
C
on
tin
ue
d
 o
n
 7 Septem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-023507 on 4 September 2018. Downloaded from 
11Roberti J, et al. BMJ Open 2018;8:e023507. doi:10.1136/bmjopen-2018-023507
Open access
A
ut
ho
r
Ye
ar
C
o
un
tr
y
S
et
ti
ng
P
at
ie
nt
s
C
ar
er
s
Ty
p
e 
o
f 
p
at
ie
nt
D
at
a 
co
lle
ct
io
n
D
at
a 
an
al
ys
is
 r
ep
o
rt
ed
S
ha
hg
ho
lia
n 
et
 a
l1
42
20
15
Ir
an
1 
H
, I
sf
ah
an
17
E
S
K
D
In
te
rv
ie
w
s
C
ol
ai
zz
i's
 m
et
ho
d
S
ha
w
 e
t 
al
27
5
20
15
N
ew
 Z
ea
la
nd
D
iv
er
se
24
E
S
K
D
In
te
rv
ie
w
s
P
he
no
m
en
ol
og
ic
al
S
he
u 
et
 a
l2
45
20
12
U
S
A
M
ar
yl
an
d
27
23
E
S
K
D
Fo
cu
s 
gr
ou
p
s
Th
em
at
ic
S
hi
h 
et
 a
l5
9
20
11
N
ew
 Z
ea
la
nd
1 
C
, N
or
th
7
E
S
K
D
In
te
rv
ie
w
s
H
er
m
en
eu
tic
al
 a
nd
 t
he
m
at
ic
S
hi
ra
zi
an
 e
t 
al
12
3
20
16
U
S
A
1 
C
, N
or
th
ea
st
23
C
K
D
Fo
cu
s 
gr
ou
p
s
Th
em
at
ic
S
ie
ve
rd
es
 e
t 
al
17
4
20
15
U
S
A
1 
C
, S
ou
th
 C
ar
ol
in
a
27
Tr
an
sp
la
nt
ed
Fo
cu
s 
gr
ou
p
s
Th
em
at
ic
S
m
ith
 e
t 
al
20
7
20
10
U
S
A
2 
C
19
E
S
K
D
Fo
cu
s 
gr
ou
p
s
C
on
te
nt
S
p
ie
rs
 e
t 
al
17
7
20
15
U
K
1 
C
, L
on
d
on
4
Tr
an
sp
la
nt
ed
In
te
rv
ie
w
s
In
te
rp
re
ta
tiv
e 
p
he
no
m
en
ol
og
ic
al
S
p
ie
rs
 e
t 
al
17
1
20
16
U
K
2 
on
lin
e 
gr
ou
p
s
10
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
S
ta
nfi
ll 
et
 a
l1
78
20
12
U
S
A
1 
C
, m
id
-S
ou
th
7
Tr
an
sp
la
nt
ed
Fo
cu
s 
gr
ou
p
s
Ite
ra
tiv
e
S
te
w
ar
t 
et
 a
l8
1
20
12
U
S
A
2 
C
, u
rb
an
19
E
S
K
D
In
te
rv
ie
w
s
C
od
in
g
Ta
ny
i e
t 
al
20
1
20
06
U
S
A
M
id
-W
es
t
16
E
S
K
D
In
te
rv
ie
w
s
C
ol
ai
zz
i's
 m
et
ho
d
Ta
ny
i e
t 
al
19
2
20
08
U
S
A
2 
C
, m
id
-W
es
t
16
E
S
K
D
In
te
rv
ie
w
s
C
ol
ai
zz
i's
 m
et
ho
d
Ta
ny
i e
t 
al
19
3
20
08
U
S
A
M
id
-W
es
t
16
E
S
K
D
In
te
rv
ie
w
s
C
ol
ai
zz
i's
 m
et
ho
d
Ta
va
re
s 
et
 a
l2
16
20
16
B
ra
zi
l
1 
H
, R
io
 d
e 
Ja
ne
iro
19
E
S
K
D
In
te
rv
ie
w
s 
an
d
 
gr
ou
p
s
C
on
te
nt
Ta
yl
or
 e
t 
al
11
1
20
16
A
us
tr
al
ia
2 
H
, S
yd
ne
y
26
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
Ta
yl
or
 e
t 
al
21
5
20
15
U
K
6 
tr
us
ts
15
11
E
S
K
D
In
te
rv
ie
w
s
C
on
st
an
t 
co
m
p
ar
is
on
Th
eo
fil
ou
 e
t 
al
12
2
20
13
G
re
ec
e
1 
H
, A
th
en
s
10
E
S
K
D
In
te
rv
ie
w
s
P
he
no
m
en
ol
og
ic
al
Th
om
é 
et
 a
l2
47
20
11
B
ra
zi
l
1H
, R
io
 G
ra
nd
e 
d
o 
S
ul
10
E
S
K
D
In
te
rv
ie
w
s
C
ul
tu
ra
l
Ti
el
en
 e
t 
al
17
9
20
11
Th
e 
N
et
he
rla
nd
s
1 
C
26
Tr
an
sp
la
nt
ed
In
te
rv
ie
w
s
Q
 m
et
ho
d
ol
og
y
Ti
je
rin
a 
et
 a
l7
6
20
06
U
S
A
8 
C
, T
ex
as
26
E
S
K
D
In
te
rv
ie
w
s
C
od
in
g
To
ng
 e
t 
al
63
20
09
A
us
tr
al
ia
4 
H
, B
ris
b
an
e,
 
S
yd
ne
y,
 M
el
b
ou
rn
e
63
C
K
D
/E
S
K
D
Fo
cu
s 
gr
ou
p
s
Th
em
at
ic
To
ng
 e
t 
al
15
2
20
13
Ita
ly
4 
C
, B
ar
i, 
M
ar
sa
la
, 
N
is
so
ria
, T
ar
an
to
22
20
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
To
ng
 e
t 
al
23
7
20
15
A
us
tr
al
ia
1 
C
, A
d
el
ai
d
e
15
C
K
D
/E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
To
nk
in
-C
rin
e 
et
 a
l1
27
20
15
U
K
9 
C
42
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
To
rc
hi
 e
t 
al
15
3
20
14
B
ra
zi
l
1 
C
, R
io
 d
e 
Ja
ne
iro
10
E
S
K
D
In
te
rv
ie
w
s
C
ol
le
ct
iv
e 
su
b
je
ct
 t
ec
hn
iq
ue
To
va
zz
i e
t 
al
11
7
20
12
Ita
ly
N
or
th
12
E
S
K
D
In
te
rv
ie
w
s
P
he
no
m
en
ol
og
ic
al
Tw
ee
d
 e
t 
al
10
9
20
05
U
K
1 
C
, L
ei
ce
st
er
9
E
S
K
D
In
te
rv
ie
w
s
P
he
no
m
en
ol
og
ic
al
Ta
b
le
 2
 
C
on
tin
ue
d
 
C
on
tin
ue
d
 o
n
 7 Septem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-023507 on 4 September 2018. Downloaded from 
12 Roberti J, et al. BMJ Open 2018;8:e023507. doi:10.1136/bmjopen-2018-023507
Open access 
A
ut
ho
r
Ye
ar
C
o
un
tr
y
S
et
ti
ng
P
at
ie
nt
s
C
ar
er
s
Ty
p
e 
o
f 
p
at
ie
nt
D
at
a 
co
lle
ct
io
n
D
at
a 
an
al
ys
is
 r
ep
o
rt
ed
U
rs
ta
d
 e
t 
al
24
2
20
12
N
or
w
ay
1 
C
15
Tr
an
sp
la
nt
ed
In
te
rv
ie
w
s
H
er
m
en
eu
tic
Va
ls
ar
aj
 e
t 
al
60
20
14
In
d
ia
1 
H
, S
ou
th
 
K
ar
na
ta
ka
10
E
S
K
D
In
te
rv
ie
w
s
P
he
no
m
en
ol
og
ic
al
Ve
le
z 
et
 a
l1
00
20
06
S
p
ai
n
1 
C
12
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
Ve
st
m
an
 e
t 
al
26
3
20
14
S
w
ed
en
1 
H
9
E
S
K
D
W
rit
te
n 
na
rr
at
iv
es
Th
em
at
ic
V
is
se
r 
et
 a
l2
76
20
09
Th
e 
N
et
he
rla
nd
s
1 
C
14
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
W
ac
ht
er
m
an
 e
t 
al
17
2
20
15
U
S
A
1 
C
16
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
W
al
ke
r 
et
 a
l1
24
20
12
U
K
1 
H
9
C
K
D
In
te
rv
ie
w
s
Th
em
at
ic
W
al
ke
r 
et
 a
l5
1
20
16
N
ew
 Z
ea
la
nd
3 
C
43
9
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
W
al
ke
r 
et
 a
l6
1
20
16
N
ew
 Z
ea
la
nd
3 
C
43
9
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
W
al
ke
r 
et
 a
l8
0
20
17
N
ew
 Z
ea
la
nd
3 
C
13
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
W
al
to
n 
et
 a
l2
58
20
02
U
S
A
1 
H
, r
ur
al
, N
or
th
w
es
t
11
E
S
K
D
In
te
rv
ie
w
s
G
ro
un
d
ed
 t
he
or
y
W
al
to
n2
57
20
07
U
S
A
1 
C
21
E
S
K
D
In
te
rv
ie
w
s
G
ro
un
d
ed
 t
he
or
y
W
ei
l2
53
20
00
U
S
A
2 
C
, r
ur
al
, 
N
or
th
w
es
t
14
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
W
el
ls
25
4
20
15
U
S
A
3 
C
, 1
 N
P,
 T
ex
as
17
17
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
W
el
ls
62
20
15
U
S
A
3 
C
, 1
 N
P,
 T
ex
as
15
21
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
W
hi
te
 e
t 
al
13
9
20
04
U
S
A
1 
C
, C
ol
or
ad
o
6
9
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
W
ie
d
er
ho
ld
 e
t 
al
18
5
20
12
G
er
m
an
y
1 
C
10
Tr
an
sp
la
nt
ed
In
te
rv
ie
w
s
C
on
te
nt
W
ilk
in
so
n 
et
 a
l7
5
20
11
U
K
Lu
to
n,
 W
es
t 
Lo
nd
on
, L
ei
ce
st
er
48
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
W
ilk
in
so
n 
et
 a
l2
33
20
14
U
K
4 
C
16
45
Tr
an
sp
la
nt
ed
In
te
rv
ie
w
s 
an
d
 
fo
cu
s 
gr
ou
p
s
Th
em
at
ic
W
ilk
in
so
n 
et
 a
l7
4
20
16
U
K
4 
C
16
45
E
S
K
D
In
te
rv
ie
w
s 
an
d
 
fo
cu
s 
gr
ou
p
s
Th
em
at
ic
W
ill
ia
m
s 
et
 a
l1
01
20
09
A
us
tr
al
ia
2 
H
20
C
K
D
In
te
rv
ie
w
s
Q
ua
lit
at
iv
e
W
ill
ia
m
s 
et
 a
l1
02
20
08
A
us
tr
al
ia
2 
H
, M
el
b
ou
rn
e
23
C
K
D
In
te
rv
ie
w
s 
an
d
 
fo
cu
s 
gr
ou
p
s
In
te
rp
re
ta
tiv
e
W
ill
ia
m
s 
et
 a
l2
61
20
09
A
us
tr
al
ia
1 
H
, M
el
b
ou
rn
e
23
C
K
D
In
te
rv
ie
w
s
Q
ua
lit
at
iv
e
W
ils
on
 e
t 
al
25
5
20
15
U
K
3 
C
15
15
E
S
K
D
Fo
cu
s 
gr
ou
p
s
Th
em
at
ic
W
in
te
rb
ot
to
m
 e
t 
al
23
0
20
12
U
K
1 
C
, N
or
th
er
n 
E
ng
la
nd
 
20
C
K
D
In
te
rv
ie
w
s
Th
em
at
ic
W
u 
et
 a
l6
6
20
15
Ta
iw
an
2 
C
, C
en
tr
al
15
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
Ta
b
le
 2
 
C
on
tin
ue
d
 
C
on
tin
ue
d
 o
n
 7 Septem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-023507 on 4 September 2018. Downloaded from 
13Roberti J, et al. BMJ Open 2018;8:e023507. doi:10.1136/bmjopen-2018-023507
Open access
A
ut
ho
r
Ye
ar
C
o
un
tr
y
S
et
ti
ng
P
at
ie
nt
s
C
ar
er
s
Ty
p
e 
o
f 
p
at
ie
nt
D
at
a 
co
lle
ct
io
n
D
at
a 
an
al
ys
is
 r
ep
o
rt
ed
X
i e
t 
al
11
0
20
11
C
an
ad
a
1 
C
, O
nt
ar
io
13
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
X
i e
t 
al
15
8
20
13
C
an
ad
a
1 
C
, O
nt
ar
io
10
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
Ye
un
 e
t 
al
14
3
20
16
S
ou
th
 K
or
ea
1 
H
, S
eo
ul
33
E
S
K
D
In
te
rv
ie
w
s
Q
 m
et
ho
d
ol
og
y
Y
ng
m
an
-U
hl
in
 e
t 
al
13
5
20
10
S
w
ed
en
S
ou
th
ea
st
14
E
S
K
D
In
te
rv
ie
w
s
P
he
no
m
en
ol
og
ic
al
Y
ng
m
an
-U
hl
in
 e
t 
al
13
2
20
16
S
w
ed
en
1 
H
, S
ou
th
ea
st
8
E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
Yo
d
ch
ai
 e
t 
al
24
9
20
16
Th
ai
la
nd
2 
H
, S
on
gk
hl
a
20
E
S
K
D
In
te
rv
ie
w
s
Q
ua
lit
at
iv
e
Yo
d
ch
ai
 e
t 
al
19
9
20
12
Th
ai
la
nd
1 
C
, S
ou
th
5
E
S
K
D
In
te
rv
ie
w
s
G
ro
un
d
ed
 t
he
or
y
Yu
 e
t 
al
11
2
20
14
S
in
ga
p
or
e
N
K
F
32
E
S
K
D
In
te
rv
ie
w
s
Th
em
at
ic
Yu
m
an
g 
et
 a
l1
44
20
09
C
an
ad
a
1 
H
, Q
ue
b
ec
9
E
S
K
D
In
te
rv
ie
w
s
C
ol
ai
zz
i's
 m
et
ho
d
Z
ie
ge
rt
 e
t 
al
21
3
20
01
S
w
ed
en
12
E
S
K
D
In
te
rv
ie
w
s
P
ra
gm
at
ic
 a
p
p
ro
ac
h
Z
ie
ge
rt
 e
t 
al
21
1
20
06
S
w
ed
en
S
ou
th
w
es
t
13
E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
Z
ie
ge
rt
 e
t 
al
21
2
20
09
S
w
ed
en
S
ou
th
w
es
t
20
E
S
K
D
In
te
rv
ie
w
s
C
on
te
nt
*I
nc
lu
d
es
 h
ea
lth
ca
re
 s
ta
ff.
C
, c
en
tr
e,
 u
ni
t 
or
 c
lin
ic
; C
K
D
, c
hr
on
ic
 k
id
ne
y 
d
is
ea
se
; D
, d
ia
ly
si
s;
 E
S
K
D
, e
nd
-s
ta
ge
 k
id
ne
y 
d
is
ea
se
; G
P,
 g
en
er
al
 p
ra
ct
ic
e;
 H
, h
os
p
ita
l; 
H
D
, h
ae
m
od
ia
ly
si
s;
 N
A
, n
ot
 a
va
ila
b
le
; N
K
F,
 N
at
io
na
l 
K
id
ne
y 
Fo
un
d
at
io
n 
(S
in
ga
p
or
e)
; N
P,
 n
ep
hr
ol
og
y 
p
ra
ct
ic
e;
 P
D
, p
er
ito
ne
al
 d
ia
ly
si
s.
Ta
b
le
 2
 
C
on
tin
ue
d
 
box 1 Illustrative quotations
structural inequalities
(Undocumented immigrant in US without access to scheduled haemodi-
alysis) When you enter through the emergency department, you arrive in 
bad shape…you need to have a high potassium or they send you home 
even though you feel you are dying. Sometimes, you crawl out when 
they decide to not do dialysis. You eat a banana because it is high in 
potassium even though you may die and you go back and wait and hope 
that they will do dialysis so that you don’t feel like you are drowning and 
so that the anxiety goes away (American patient).52
My mother got some help from DIF (Mexican social assistance office), 
it was five haemodialysis sessions; when there was no session left, we 
went to a private centre, there is a foundation there and they helped 
us… they gave me eight sessions. After that, my mom went to DIF in 
Zapopan again and they sent us to DIF in Guadalajara. We got some help 
there (Mexican patient without coverage).47
Workload
Sometimes I have to sit and wait at least an hour and I have to call and 
say my ride is not here yet, which makes me late getting there, which 
makes me late getting on the machine, which makes me late getting 
off the machine. And then… coming to pick you up, if you’re not ready 
when they get there, they will leave you and you’ll have to sit and wait 
and wait and wait (American patient).86
It is always in the back of your mind that it (the transplant) will fail, at 
times. And I think if anything that makes you more inclined to comply 
with your treatment, comply with your medication because at the end 
of the day if, you know, if you do the utmost that you can and you 
take your medicine and you go to your follow up appointments, then 
there’s hopefully less chance of it failing in the long run (woman, 3 
years+post-transplant).175
I suppose mine being genetic. It’s been very difficult to find what kind 
of diet you’re supposed to follow. You read one bit of information and 
it tells you this and you read another bit and it tells you don’t eat that, 
which the other one said you must eat. there’s no clear guideline on 
what it is you can or can’t eat (man, 38 years, CKD stage 3).94
It was a lot more work because of all the things that you had to learn… 
I don’t eat out anymore… It’s tough taking so many pills (patient with 
CKD).92
Capacity
Before she left (pause) when everything was happy and happy sort 
of thing, you know, I think it was—she was going to give a kidney 
to somebody else and somebody else was going to give a kidney to 
somebody and somebody was going to give a kidney to me—like a 
triangle… she was willing to do that. It didn’t happen, um (pause) ‘cos 
she left (UK patient).39
it’s a kind of tiredness that you wouldn’t wish on your worst enemy… 
when you can’t read, you’re too tired to watch the telly, you’re too tired 
to do anything, because your brain is so tired like all of you… it feels 
like you’re kind of hollow inside… like it’s only a kind of shell that’s 
functioning.137
Well about five years ago, I went to the hospital because I wasn’t feel-
ing good and they took my blood pressure and it was 200 over some-
thing…Then while they were trying to get my blood pressure down, 
they said something about my kidneys. And I didn’t know the connec-
tion between high blood pressure and kidneys (Evan, African-American 
male, 50, CKD stage 3).35
It wasn’t till about 2 years ago, until I fully understood and I’ve had the 
kidney disease from the age of 15, what exactly my (kidney) function was 
and I got a fright. No one had ever told me (man, 38 years, CKD stage 3).94
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risk, whatever their treatment modality, as in the case of 
many undocumented and uninsured immigrants in the 
USA.35 47–49 52 66 In countries with poor healthcare infra-
structure, patients reported shortage of public specialised 
hospitals, long delays to undergo examinations, limited 
number of haemodialysis machines available, lack of ward 
space or poor bed conditions in hospitals, for example, 
poor hygiene, worn-out mattresses, shortage of linen; to 
avoid delays, patients sometimes had tests performed by 
private providers.40 50 60 67 68
When home dialysis was available, patients had to pay for 
transport to training, appointments and other check-ups; 
moreover, some equipment, supplies, increased utility 
bills and home modifications represented unexpected 
expenses.51 53 61 69–73 In countries with coverage of RRT, 
for patients whose first language was different from that 
where treatment was received, as in the case of migrants, 
communication was a barrier for discussions with health-
care professionals; family members and neighbours acted 
as translators at appointments.53 74–76 Where language was 
shared, communications between clinicians and patients 
of different ethnic origins—for example, Australian 
Aborigines and New Zealand Maoris—was often itself a 
source of conflict and disadvantage, because of preju-
dice.53 57–59 77–82
In some countries, the transplantation procedure 
could be particularly expensive, even at public hospi-
tals.35 47–49 66 83 Moreover, patients sometimes found that 
the expensive immunosuppressants necessary after the 
transplant were not covered by their insurance; other 
patients who obtained information about the high costs 
of immunosuppressants and realising that they could not 
afford them, were forced to continue with dialysis until it 
failed.49 83–85 In Mexico, structural constraints resulted in 
transplanted patients being sent back to small peripheral 
clinics with no transplantation expertise, increasing the 
risk of iatrogenic or poorly managed complications.83
Housing conditions
Unsuitable housing was a barrier to home dialysis if it 
could not accommodate equipment, and was impossible 
without an adequate electricity supply.51 61 In rented 
accommodation, landlords might not approve of neces-
sary modifications. Home dialysis was not a treatment 
option for those with no fixed abode.51 61 70 86
Employment status
Patients who were physically able to continue working 
often had informal or temporary jobs, with diminished 
income; others were forced into unemployment, leading 
to new financial problems.39 45 52 60 69 72 87–91 Unemployed 
patients in the USA were covered by government or state 
schemes; however, this coverage either diminished or 
ceased if they found work with a new insurance.35 52
Patient workload
Self-care
People with CKD and ESKD had complex medication 
regimens managed through dispensing aids, daily activ-
ities associated with medication taking such as meals, 
family support or a combination of these.40 46 71 86 92–106 
Anticipating dialysis, patients underwent vascular access, 
a way to reach the blood for haemodialysis, undergoing 
minor surgery and care needed to be taken to prevent 
infections or clotting.66 107–110 To care for their vascular 
access, patients kept the access area clean, changed 
bandages, restricted themselves from lifting heavy objects 
and were alert for pain or hardness in the area.108 111
Patients controlled their diets and fluid intake between 
dialysis sessions, and managed food cravings and thirst 
with strategies such as thinking of the potential detri-
mental consequences of drinking water, avoiding 
thoughts and behaviours that could trigger thirst and 
modifying social activities to minimise exposure to hot 
weather, social pressure and temptation to intake certain 
foods or fluids.46 63 112–120 Women also faced potential 
family conflicts if they followed prescribed diets.45 62 121–124 
In certain cultures, including immigrants who preserved 
their customs in other countries, the perceived associa-
tion of a rich diet and wealth acted as a barrier to adher-
ence to a restrictive diet, essential to self-care, as patients 
feared being stigmatised as poor.62 121 125
Travel and time management
People with ESKD travelled to haemodialysis centres 
three times a week, received treatment for several 
hours and then transported themselves home again; 
very often, transportation represented a problem for 
box 1 Continued
Control and decision-making
I have free rein of whatever days I want to take off. They don’t tell me 
when I have to dialyse or when I can’t dialyse. Everything is under 
my control. That’s what I like (talking on home dialysis, patient from 
Canada).158
If I’m going to feel this bad for the rest of my life, do I just want to end it 
now? (woman, 40s, CKD stage 4).63
Carers’ involvement
I just sit here like a robot. Nurses asked me to buy items that my mother 
needed. They never told me why she needed them. They ordered me to 
pay for dialysis, laboratory investigations and other things. I don't like 
it when I do not know the reason behind my actions. I am sad to see 
myself as a fool being tossed around (caregiver from Nigeria).65
End of life
Then (the home care nurse) said ‘Well you haven’t got to go on. We’ll 
make it quite peaceful for you to pass on'. They can tell you, but it’s your 
body. It’s up to me to decide what I want to do (patient from the UK).205
I have heard (about) a lot of people that died on dialysis and had strokes 
on dialysis… Once I sit down there, I don’t know whether I’m gonna 
come out alive or dead (Berta, aged 45 years, blind amputee, dialysis 
patient for 18 months).76
I think about (death) everyday. I mean you can't help it. I know that it is a 
terminal illness and it's not going to get better and that there is only one 
way out (wife of a Canadian patient on peritoneal dialysis).286
CKD, chronic kidney disease. 
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Table 4 Main challenges related to burden of treatment
Challenge
Group of patient 
mostly affected
Type of country 
mostly affected Severity
Limited access to healthcare for the uninsured or underinsured. CKD, ESKD LMIC +++
Dialysis, transplant surgery, immunosuppressive drugs were often beyond the 
reach of low-income patients.
ESKD LMIC +++
Healthcare was often fragmented and of indeterminate duration for the 
uninsured or underinsured.
CKD, ESKD LMIC +++
In settings with healthcare coverage, socially disadvantaged patients found it 
difficult to access financial support.
CKD, ESKD HIC ++
Fund-raising was important for those who were uninsured or underinsured. ESKD LMIC +++
For non-native speakers, language was an important barrier for having a 
discussion with care providers.
CKD, ESKD LMIC, HIC ++
Patients were often poorly informed about disease progression and treatment 
options.
CKD, ESKD LMIC, HIC ++
Patients and carers had to identify institutions to obtain diagnosis, laboratory 
results and treatment.
CKD, ESKD LMIC ++
Homelessness, unsuitable housing, lack of utilities, critical to self-care and 
home dialysis.
ESKD HIC, LMIC ++
Loss of employment may lead to uninsurance or underinsurance limiting or 
preventing access to treatment.
ESKD HIC, LMIC +++
Complex medication regimens were managed through dispensing aids, 
associated activities, family support.
CKD, ESKD HIC, LMIC +
When taking care of their vascular access, patients made efforts to protect the 
arm.
ESKD HIC, LMIC +
Patients controlled diets and fluid intake, modified social activities to minimise 
exposure and pressure.
CKD, ESKD HIC, LMIC ++
Patients often travelled for long distances to dialysis centres, three times a 
week.
ESKD HIC, LMIC ++
Home dialysis patients had to pay transport to training, appointments and 
other check-ups.
ESKD HIC, LMIC ++
Patients arranged daily activities between sessions. ESKD HIC, LMIC +
For home dialysis, training was required with extended periods off work. ESKD HIC, LMIC +
For home dialysis, homes needed physical adaptation. ESKD HIC, LMIC +
For home dialysis, tasks were managing treatment, monitoring, titrating 
medications, adopting aseptic techniques.
ESKD HIC, LMIC ++
Pretransplantation, specific adjustment tasks included: hospital visits, tests 
and organising payment for treatment.
ESKD HIC, LMIC
Some people needed to negotiate donation of a kidney by living relatives or 
others.
ESKD HIC, LMIC ++
Transplanted patients managed complex medication regimens. ESKD HIC, LMIC +
Transplanted patients needed to manage relationships, finances and family 
responsibilities.
ESKD HIC, LMIC ++
Symptoms associated with dialysis limited daily activities, sometimes 
overlooked by healthcare professionals.
ESKD HIC, LMIC ++
When in poor health, wider networks were necessary for daily activities, 
transportation, symptom management.
ESKD HIC, LMIC ++
Information on disease and treatment was often insufficient or difficult to 
comprehend.
ESKD HIC, LMIC ++
Information about immunosuppression was hard to obtain. ESKD HIC, LMIC ++
Lack of social support was a frequently reported problem. ESKD HIC, LMIC ++
Continued
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patients because of pick-up delays, long distances or 
high costs.15 47–49 53 76 86 126–133 Patients receiving dial-
ysis arranged their daily activities between treatment 
sessions, adjusted the timing and intensity of their 
activities to their fatigue and tried to schedule medical 
appointments all on one day to avoid further inter-
actions with the healthcare system.55 134–145 The treat-
ment was seen by most patients as an emotional and 
time imposition that caused boredom and frustra-
tion.63 146–152 Time was often spent waiting for visits, 
prescriptions and tests.55 134–145 153 Parents also arranged 
child care while they were in sessions, or had to travel 
for treatment.49 53 55 154 155
Home dialysis
For patients receiving home dialysis, training was 
required which necessitated extended periods of leave 
from work.61 70 156–158 They and their families had to adapt 
their home to accommodate equipment and materials, 
and spent more time cleaning in case healthcare workers 
assessed their housing conditions.152 158–162 Tasks asso-
ciated included managing treatment at set times each 
day, recording blood pressure and body weight, titrating 
medications and adopting aseptic techniques, as well as 
adhering to diet and fluid restrictions.156 157 163 In the case 
of developing peritonitis, workload increased as antibi-
otics had to be reconstituted and injected.156 157
Pretransplantation adaptation
People with ESKD adjusted to being on the transplant 
waiting list and prepared for the possibility of receiving a 
kidney from a deceased donor at any time.43 115 133 164–170 
The tasks included hospital visits, several investigations 
and tests, saving money for the operation and main-
taining robust health; many potential recipients felt 
overwhelmed by all that was necessary.132 133 164 165 170–173 
Talking to others about their requirement for a kidney 
transplant involved making the request itself to potential 
living donors, educating people about CKD, treatment 
options and donation.39 47 164 174
Post-transplantation adjustment
After transplantation, patients’ workload included finan-
cial and occupational changes resulting from a new type 
of treatment and status, managing complex medication 
regimens and managing social relations.84 85 175–180 These 
tasks had to be balanced against the work of safeguarding 
access to healthcare, organising their disability insur-
ance, interacting with healthcare providers, managing 
symptoms, monitoring medication side effects and 
managing self-care in relation to diet, fluid and physical 
activity.84 85 175–180 Although transplantation was seen as 
a route back to normality, it was laden with ambiguous 
feelings towards the donor, unanticipated challenges in 
forming or maintaining relationships, financial worries, 
the responsibility of supporting their family, disappoint-
ments when side effects were noticed and a prevailing 
prognostic uncertainty.83 85 175–177 181–186
Navigating healthcare structures
Very often, patients had to identify and call on the 
appropriate institutions to obtain a diagnosis, laboratory 
exams, treatment or coverage; contacting several public 
and private healthcare providers, social insurance offices, 
charity organisations and non-governmental organisa-
tions.48 49 125 161 In settings with coverage of RRT, socio-
economically disadvantaged patients could also find it 
difficult to access financial support and navigate the social 
support system, which resulted in not receiving the assis-
tance to which they were entitled.51 Lack of continuity 
of care contributed to patients using services without 
sufficient expertise in CKD or ESKD, such as emer-
gency departments or peripheral health centres.49 101 
The efficiency focus of the medical system was perceived 
by patients and professionals as a barrier to a personal 
connection; moreover, patients also recognised profes-
sionals’ dismissive attitudes towards patients’ experiential 
knowledge.102 173
Negotiating costs and fund-raising
Those patients and carers in countries with limited health 
coverage needed to perform additional work; poor fami-
lies sold goods, products or services, organised raffles 
to collect money or obtained loans.47–49 125 They also 
contacted treatment centres, other patients, hospitals 
and non-government organisations to ask for free dialysis 
sessions or medication. For this reason, disadvantaged 
people were advised by healthcare staff on how to seek 
help in charities and advocacy organisations.47 In more 
Challenge
Group of patient 
mostly affected
Type of country 
mostly affected Severity
Many clinicians failed to discuss care, eligibility for transplant and potential 
donors.
CKD, ESKD HIC, LMIC ++
Carers needed more information on dialysis techniques to feel confident. ESKD HIC +
Patients and carers emphasised self-determination, autonomy and dignity 
when nearing end of life.
ESKD HIC ++
Severity: + mild, ++ moderate, +++ very severe. 
CKD, chronic kidney disease; ESKD, end-stage kidney disease; HIC, high-income country; LMIC, low-income and middle-
income country.
Table 4 Continued 
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affluent settings, patients also struggled to negotiate 
coverage of extra expenses, such as those related to home 
dialysis or conservative management.51 161
Capacity
Physical and mental capacity
The ability of people with ESKD to carry out daily activ-
ities, including their paid job, was limited by symptoms 
associated with the disease and dialysis treatment, such 
as pain, fatigue, anxiety, depression and sexual prob-
lems,37 44 55 63 90 96 138 140 154 187–201 sometimes overlooked 
by healthcare professionals.58 94 101 202–204 When in poor 
physical health, patients relied on wider family networks 
and neighbours to help with activities related to BoT 
such as scheduling and attending medical appoint-
ments, arranging transportation to those appointments, 
ordering and arranging medical supplies and training; 
also, other daily tasks such as food preparation, or shop-
ping.37 118 161 205–209 Carers were involved in the dialysis proce-
dure, accompanying patients to dialysis and responding 
to psychosocial needs.45 69 97 129 141 143 161 210–216 Patients’ 
capacity to carry out the activities related to healthcare 
were affected by insufficient financial resources and the 
fear of catastrophic consequences, such as death because 
of lack of dialysis treatment or immunosuppressive medi-
cation in the case of transplanted patients.47 49 52 217 218
Managing information
Obtaining information on the disease and treatment 
was a significant burden for patients and carers. Patients 
reported that their information on the disease and 
treatment options was often insufficient or difficult to 
comprehend, particularly during the early stages of 
their trajectory, independent of income or coverage 
level.38 50 57 58 61 63 64 77 92 109 121 125 127–131 188 205 219–230 Patients 
may not have asked for clarification for fear of not under-
standing or because they did not even know what to ask; 
the desire for more patient-centred care were widely 
expressed. Short clinic visits, unknown technical jargon 
and high levels of anxiety were barriers to accessing infor-
mation.61 102 223 231–234 Other patients could sometimes 
supply information about dialysis options, travelling, 
hygiene regimens, dietary restrictions, benefit advice, 
timing of treatment and pain management.117 174 235–238 
For organ donation and transplantation, people usually 
received information through discussions with other 
patients, providers, social workers, financial representa-
tives, the internet and, in affluent populations, informa-
tive meetings.117 174 235–238 In relation to transplantation, 
patients reported they needed practical information 
about the unexpected side effects of immunosuppres-
sive medication; most frequently mentioned were higher 
risk of cancer, infections, weight gain and fragile 
skin.178 184 185 239–242 Other information needs for trans-
planted patients included coping with emotions related 
to the transplant, what to do when a suitable organ 
became available, alternatives to transplantation and how 
the waiting list worked.240 242–245 Family members were 
afraid to bother the healthcare team,246 and perceiving 
little power in comparison to healthcare professionals, 
downplayed their knowledge in front of them.210 Patients 
and carers were responsible for obtaining and carrying 
their medical files and test results to appointments when 
the healthcare administrative systems were not inte-
grated.49 125 Some had anticipated that transplantation 
would offer dramatic health improvement but were disap-
pointed when they experienced side effects, particularly 
cancer.44 63 101 106 122 167 190 193 199 206 214 247–251
Social support
Most people highlighted the support from family, 
neighbours, friends, staff, other patients and 
church communities; friends, staff and spiritual 
groups were particularly important for those living 
alone.39 44 60 62 215 247 249 252–258 A lack of social support 
was also frequently reported.44 60 247 259 In a UK study, 
patients' socioeconomic disadvantage adversely affected 
the availability of social support, and it was suggested 
that personal relationships sometimes broke down when 
potential donors declined to donate.39 Attending dialysis 
was sometimes seen as a social outlet, where they could 
make friends with staff and patients. Younger partici-
pants often considered the schedule flexibility of home 
dialysis as an opportunity for maintaining their employ-
ment and contact with their family and established social 
networks.61 152 To demonstrate resilience, some patients 
tried to maintain a sense of normalcy, integrating the dial-
ysis community into their social network.42 139 210 260
Experienced control
Personal control
Feelings of personal control were achieved through 
learning how to manage CKD and ESKD, finding a balance 
between illness and normalcy, or even denying the seri-
ousness of their condition.218 260 261 The experience of feel-
ings of personal control led to increased self-confidence 
and well-being.15 189 251 Strategies for maintaining control 
included requesting tests, withholding information from 
clinicians, monitoring and modifying their treatments 
and checking the activities of dialysis nurses assisting 
them.139 246 251 262–265 People with ESKD experimented 
with their therapy to determine if the prescriptions were 
really necessary, they also shortened dialysis hours to 
reduce worsening symptoms, to meet work commitments, 
or to participate in an unexpected social situation.54 55 
Lengthening treatment hours could facilitate higher than 
usual fluid removal or managing symptoms.54 55 Some 
patients entrusted decisions entirely to the care team, 
and this promoted feelings of security.61 70 102 107 266 267 
The main barrier to personal control was lack of informa-
tion about treatments, test results and the course of their 
illness and that they could not choose when and where 
to travel.15 43 61 63 197 239 268 However, even when patients 
knew they were not in control, they felt unsafe if the treat-
ment went differently from what was expected.269 Patients 
recognised prognostic uncertainty, and their own fear of 
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incompetence as an obstacle to choosing the appropriate 
dialysis modality.54 72 92 132 133 150 161 223 251 268 270–274 For many 
patients, home dialysis restored a sense of control and 
freedom to manage their schedule, especially if it was 
nocturnal.51 70 158 220 263 275 Dependence on emergency 
care or on fund-raising tasks to cover life-saving treat-
ment represented a severe case of lack of experienced 
control.35 47–49 52 66
Control and decision-making
Control translated into participation in decision-making, 
which was affected by the healthcare staff’s attitude 
towards the patients’ adherence to treatment.236 Lack 
of choice in decision-making about dialysis modality was 
very common; when possible, modality was negotiated 
and agreed after discussions with clinicians and family 
members, reading educational material or attending 
informational meetings.202 248 270 273 274 276–278 Home dial-
ysis patients appreciated training to build confidence 
and skills to use the machine.54 70 111 270 279 280 Patients in 
dialysis aspired to improve their situation by receiving 
a transplant, motivating them to adhere to treatment; 
other motivations included family, especially their chil-
dren, work and beliefs.55 58 281 People with ESKD whose 
clinicians failed to discuss care, eligibility and ineligi-
bility for transplant, and potential donors with them 
felt disempowered.39 55 57 58 77 78 169 282 When relatives 
offered to donate a kidney, many patients felt reluctant 
to accept this because of their concerns about the future 
health of the donor; other patients had reservations 
about accepting kidneys from deceased donors because 
of the donor’s age and medical history.172 181 235 Once 
transplanted, the main clinical objective was preserving 
the graft. However, the disease and its treatment 
continued to be a significant burden on patients’ social 
capital and financial capacity, with unexpected side 
effects.49 63 89 96 167 283–285
Carers involvement
Relatives wanted to be involved in discussions on dialysis 
modality as dialysis would take up a large part of their 
lives.55 70 111 156–158 223 279 286 Carers of patients on home dial-
ysis needed to know more about the dialysis techniques 
to feel confident about self-managing the treatment, they 
stressed the importance of 24 hours telephone access 
for advice.61 69 Family members were afraid to bother 
the healthcare team,246 and perceiving little power in 
comparison to healthcare professionals, used strategies 
to downplay their knowledge of the disease or the treat-
ment in front of them.210 287 To cope with caring, carers 
sought support in psychiatric help or religion when avail-
able, or support in religion.141 247 Patients who decided to 
stop dialysis did not usually ask for their carers’ opinion; 
when physicians thought the patient was too ill to decide, 
carers were consulted and felt death could be liberating 
if the patient was in pain and with no response to treat-
ment.134 141 161
End-of-life decisions
Some patients felt that advance care planning (ACP) 
was hard and unnecessary as they trusted their fami-
lies to make decisions; others were less concerned, 
trusted their healthcare team and felt empow-
ered.236 288 289 Family members felt ACP was necessary as a 
means to protect patients.290–292 At the end of life, main-
taining control was a struggle with respect to autonomy 
and dignity.134 136 205 251 Patients based their dialysis with-
drawal or non-acceptance decision on having lived a full 
life, on nature taking its course, on their fear of being a 
burden for their families, their bodies being invaded and 
dialysis accelerating death.128 293 For some, the decision 
to withdraw from dialysis meant asserting their self-de-
termination.251 294 Carers’ acceptance of patients’ deci-
sion was influenced by the perception of conservative 
management as a non-invasive treatment, the advanced 
age of the patient and the lack of benefit received from 
haemodialysis.64 128 134 161 Although family members were 
often uncomfortable about making end-of-life decisions, 
they tended to recognise it was important to respect the 
patient's wishes.202 233 292 Figure 2 shows thematic schema 
of experienced control and cognitive authority in CKD.
dIsCussIOn
Our findings demonstrate that the work and capacity of 
patients and carers are highly unstable situational factors 
that make up the BoT. Capacity is particularly diminished 
by socioeconomic factors, which ultimately exacerbates 
the work of patients and their carers; this may occur even 
in regions with universal health coverage. Particularly in 
LMICs, patients with ESKD are often underinsured or not 
at all, which makes it almost impossible for them to attain 
life-saving treatments. Patients with ESKD can be caught 
in a vicious cycle, whereby they lose their job and health 
insurance because of ill health or because they need 
time off from work to attend dialysis, leading to exacer-
bations in disease, lack of financial access to treatment 
and difficulty obtaining a job because of poor health. 
Patients often fear catastrophic consequences due to a 
lack of financial capacity, and make strenuous efforts to 
prevent them. Thematic syntheses with robust methods 
have covered different aspects of being a patient with 
CKD.295–308 Here, we focused on three elements of BoT, 
namely workload, capacity and experienced control, to 
develop an understanding of the BoT of CKD, focusing 
on ESKD and including the experiences of patients in 
contexts of structural inequalities.
Worldwide, many individuals with CKD and especially 
with ESKD receive no treatment or receive only frag-
mented care.8 35 309–314 Millions of preventable deaths 
occur because of lack of access to RRT.9 Moreover, in some 
LMICs with universal health coverage, resources may be 
limited because of geography or poor infrastructure; in 
such cases, the use of free health providers can create 
delays that compromise the treatment itself, resulting 
in patients struggling to pay for private providers. When 
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this occurs, healthcare becomes fragmented and unco-
ordinated. Even in some modern welfare states, health 
inequalities persist, particularly affecting minorities, those 
who are unemployed or undocumented.315 One example 
is the use of emergency haemodialysis by undocumented 
and uninsured immigrants with ESKD.52 Several studies 
have highlighted the imperative necessity to address this 
disturbing reality.316–323
When health systems fail to meet patients’ treatment 
needs, patients mobilise resources and develop coping 
strategies such as accepting charity or selling assets.13 29 312 
This distressing scenario adds to their workload and very 
easily overwhelms patients’ capacity. Transportation to 
and from dialysis centres is a frequent challenge, it is 
time-consuming, costly or simply not available. Those 
patients living in non-urban areas in countries where 
home dialysis is not available have to travel long distances 
or relocate to access treatment; some may be faced with 
the decision of leaving their young children in the care 
of others for long periods of time. In many LMICs, the 
costs of RRT remain prohibited for both individuals and 
healthcare systems; dialysis and transplantation costs often 
lead to financial ruin of the family, discontinuation and 
death.324 In fact, patients, families and healthcare profes-
sionals are burdened with having to choose between life 
and death.324 On the other hand, in countries with robust 
health coverage, patients may feel overwhelmed even by 
having to travel short distances to the treatment centre 
every 2 days, especially if they do not have support or, if 
offered home dialysis, they may experience social isola-
tion, unexpected costs and lack of sufficient technical 
assistance. In settings in which RRT costs are covered, 
patients may have the choice of not initiating or with-
drawing from dialysis.324 Among other factors, advanced 
age, white ethnicity and chronic disease are associated 
with dialysis withdrawal.325
Support from social networks, professionals and 
other patients is critical in improving patient’s capacity. 
Spirituality and church communities are significant 
resources for coping with illness and its treatment, as 
seen in several studies.21 201 249 257 326–329 However, social 
support is not guaranteed; in some cultures, patients 
perceive lack of support by their own networks caused by 
discrimination because of their illness, leading to intol-
erable levels of BoT.44 60 247 259 It has also been shown that 
informal care offered by family, friends or neighbours 
can burden patients through uncomfortable feelings of 
dependency or the obligation to have an optimistic atti-
tude towards their condition.330 Our findings support 
this view; patients often fear becoming a burden on 
their families, which affects their decisions related to 
treatment options.
We confirmed that patients’ capacity can be under-
mined by insufficient or inadequate information. 
Deficits in communication between patients and profes-
sionals are endemic and rooted in structural and system 
factors.20 30 296 308 331 This shortfall affects decisions 
regarding dialysis modality, medication management 
and the possibility of using a living donation. Patient 
discussions with professionals must result in a collabora-
tive partnership and should not simply provide informa-
tion.330 For example, patients’ concerns and expectations 
about waitlists, eligibility and allocation for transplan-
tation could be addressed via additional information, 
Figure 2 Thematic schema of experienced control and cognitive authority in chronic kidney disease.
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clinical conversations and access to specialised psycholog-
ical therapists.306
Immigrant populations do not always have access to 
healthcare; when they do, language, cultural and religious 
differences can act as barriers to care and contribute to 
the BoT. In high-income countries, the need to provide 
RRT for migrants and refugees with ESKD will increase 
as more people are displaced to countries where RRT 
is available; this situation poses ethical challenges at 
the societal and individual levels.321 It is necessary to 
promote and support equitable access to care for those 
living within any border by means of organisational posi-
tion statements and focused research.322 For migrants 
with access to care, culturally competent navigator 
programmes could contribute to the improvement of 
healthcare disparities.332
Surprisingly, patients who undergo haemodialysis 
tend to perceive that staff underestimate their capaci-
ties.58 94 101 202–204 When healthcare professionals do not 
take into consideration patients’ knowledge or values, 
a diminished participation in self-care and relationally 
induced non-adherence can occur. Treatment plans 
should be discussed against an assessment of patient and 
caregiver capacity, as well as their material, social and 
cognitive resources.28 333
Changes in treatment may be needed as CKD progresses 
to its later stages—symptom control may become the main 
treatment focus.10 11 Our results relate predominantly to 
the BoT of patients with ESKD, as most reports included 
in this systematic review have addressed the experiences 
of this group of patients. Indeed, a large proportion 
of patients with early stage CKD are unaware of their 
diagnosis.334 In patients whose kidney function will not 
decline to a point necessitating RRT, the overall BoT may 
be related to a reduction of risk.10 11 In the later stages of 
CKD, symptom control may become the main treatment 
focus, and the time-consuming and invasive treatment 
of dialysis, by any modality, and all tasks related to dial-
ysis represent considerable portions of the burden.10 11 
Moreover, the BoT is influenced by patients’ financial 
resources, family support and comorbidities, as well as the 
healthcare setting. In fact, because of the likely coexis-
tence of multiple conditions, elderly patients experience 
a greater BoT than do younger patients.24 Management 
should be coordinated among professionals, particularly 
for patients with ESKD and multiple morbidities,23 who 
frequently experience fragmented care with a substantial 
time and travel burden, as well as contradictory health-
care advice.23
Challenged by constraints, a patient’s sense of control 
can become fragile. As seen in our review, patients often 
employ a range of strategies to retain their control, 
such as withholding clinical information from profes-
sionals, asking for additional tests or modifying their 
treatment. Although a patient’s capacity to cope with 
BoT is often exceeded, healthcare systems increasingly 
delegate responsibilities to patients and carers, focusing 
on self-management and compliance.30 335 When 
overwhelmed, patients may be forced to renegotiate their 
responsibilities with actors in the health system and their 
own social networks.29
Our review has important limitations. The variety of 
methodologies, quality of reporting and heterogeneity 
of perspectives make synthesis difficult. Only studies that 
included face-to-face interviews were included to capture 
rich qualitative data, and studies that reported methods 
such as telephone and postal questionnaires or surveys 
were excluded. Studies with paediatric patients and/or 
their carers were excluded, as BoT may significantly differ. 
Although the use of framework analysis can improve the 
transparency of coding and identify underlying assump-
tions, it can also be interpreted as a limitation because 
findings may be influenced by and connected to these 
theories. For a more global perspective, studies published 
in other languages could have been included. Grey liter-
ature was excluded to manage the scope of the review. 
We analysed data with a coding framework supported by 
middle-range theories to understand the work involved in 
being a person with CKD and how practises are organised 
and integrated into social contexts. The major strengths 
of this study are the comprehensive inclusion of publica-
tions in the English, Spanish and Portuguese languages 
to understand the experience of patients in LMICs, 
which may enhance the transferability of our findings, 
the broad description of BoT across all stages of CKD and 
the use of theories to underpin our findings. However, 
the included studies representing only some LMICs can 
hardly be presumed to reflect patients’ experiences in 
these countries.
COnClusIOn
To the best of our knowledge, this is the first theory-led 
review that focuses on the structural inequalities that 
shape patients' and caregivers’ experiences related to 
BoT in CKD. The inclusion of LMICs extends our under-
standing of the experiences of individuals living in these 
countries and the work they undertake to manage their 
conditions. CKD can result in invasive and exhausting 
BoT, which is exacerbated in contexts of limited health 
coverage, socioeconomic disadvantages and marked 
imbalances in power. An urgent, collaborative, multi-
pronged approach is needed to address the overwhelming 
BoT of CKD that, in many populations, results in prema-
ture death.8 312 However, knowledge gaps persist in 
resource-limited settings and the nephrology community 
need to quantify the burden of CKD, understand its social 
impact, raise awareness of the disease among healthcare 
workers and advocate for cost-effective and setting-spe-
cific detection and prevention strategies.9 324 336 337 The 
design of innovative policies, interventions and activ-
ities are warranted to support and empower patients, 
considering the constraints and structure of systems that 
patients navigate in their disease trajectory. This will lead 
to a better understand of their burden, with the objective 
of improving quality of care and the illness experience.
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